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Abstract 
The biomanufacturing industry is a highly in-demand field, being valued at $13.3 billion in 2018, 
as it is utilized for the production of biologics such as monoclonal antibodies and vaccines in the 
treatment of diseases. Most of these manufacturing processes utilize suspension bioreactors, 
whereas there has been a slower development in large scale manufacturing involving adherent 
cell cultures. The current standard for adherent bioreactors is the utilization of microcarriers to 
provide a substrate for cellular adherence. However, the culture start-up process is inefficient and 
time-consuming, characterized by low attachment efficiencies and the generation of shear forces 
capable of detaching cells. This project aims to design a novel bioreactor system which supports 
adherent cell culture, while improving upon cellular adherence and volumetric efficiency. The 
final design incorporated a packed bed of microcarriers within a continuous pumping system, 
thereby promoting bead-to-bead migration and the recycling of unattached cells. The system was 
tested for proper continuous fluid flow, and the microcarriers were optimized to maximize 
surface area and cellular attachment potential. 
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Executive Summary 
I. Introduction 
 A bioreactor is a manufactured device that is able to support an environment that allows 
biological functions to occur. Bioreactors can be utilized for specialized applications such as 
microbial fermentation and the production of biological molecules, such as vaccines, which 
require the functionality of healthy cells in order to be produced. The most fundamental principle 
of bioreactors is promoting robust cell growth at various densities by offering the ability to scale 
up or scale down in terms of working volume of cell media. This scale up process grants greater 
control and functionality in large-scale commercial manufacturing as well as in clinical trials and 
process development [1]. Within the biomanufacturing industry, suspension cultures are typically 
utilized in bioreactor processes due to their ease of scalability, allowing large cell densities to be 
achieved. In comparison, the translation of adherent cell culture into these larger 
biomanufacturing sizes has been more difficult since the presence and amount of surface area for 
cellular attachment is the main limiting factor. 
Cellular adherence is the process in which cells are capable of interacting with external 
biomolecules through focal adhesion complexes (FACs), large transmembrane protein 
complexes that allows the cytoskeleton of a cell to connect to the extracellular matrix. These 
FACs typically involve integrins on the cell surface. Adherent cell culture aims to promote this 
attachment in order to support adherent cells. For example, a protein commonly found in cell 
culture media is fibronectin, which is capable of binding integrins and FACs. In culture, these 
proteins found in media are capable of adhering onto cell culture surfaces, enabling cells over 
time to adhere and slowly spread out through interactions with the proteins [2]. As such, 
adherent cell culture focuses on the utilization and optimization of substrates in order to 
maximize cellular adherence and achieve the highest product yields in the smallest volume 
possible. When characterizing adherent bioreactor systems, attachment efficiency and cellular 
viability are important criteria to consider.  
It has been highlighted that with current microcarrier systems in place, attachment 
efficiency is an issue due to the repeated shear forces applied during the culture setup which is 
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capable of ripping cells off of the microcarriers. This occurs in the current bioreactor technology 
which combines microcarriers with stirred tank bioreactor systems. The initial culturing process 
utilizes intermittent stirring; however, this stirring combined with the impeller is capable of 
generating repeated shear stresses. As demonstrated with rabbit mesenchymal stem cells, GE 
Cytodex microcarriers have had as low as 16.7% of the total amount of inoculated cells attached 
to the microcarriers, and even after further optimization, only 65% attachment efficiency was 
observed [3]. Improving these attachment efficiencies for adherent bioreactors would yield 
higher cell densities, and ultimately, increase the capabilities of biomanufacturing scalability. As 
such, the overall goals of this project are to break down the design and operation of current 
adherent cell culture technology, and fabricate a novel bioreactor design capable of increasing 
adherent efficiency and volumetric efficiency with the potential for pharmaceutical and industry 
translation.  
 
II. Device Design 
Design Objectives 
During the design process, the team broke down the initial design objectives into more in-depth 
needs and wants, and then used a pairwise comparison chart to produce the following ranked 
objectives for the bioreactor system: 
  
1. Non-disruptive to cells 
2. Volumetric Efficiency of the Bioreactor 
3. Promotion of Maximum Confluency 
 
Functions and Means 
Afterwards, the team brainstormed various functions to address these objectives. Further 
research was done on each function to find different means of achieving each function. A 
Functions/Means table was created as displayed below in Figure ES1: 
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Figure ES1. Functions-Means Table 
Alternative Designs 
The team generated several alternative designs that would be able to accomplish these objectives, 
as shown below. 
Stackable Scaffold Bioreactor 
 This design consisted of a stackable scaffold which would be placed inside the bioreactor 
vessel. The stackability of the scaffold allows for different scalability options, as more or less 
scaffolding could be stacked depending on the desired size of the bioreactor. The impeller 
system which is typically found in stirred tank bioreactors is replaced with a pumping 
mechanism that would pump the culture media from the bottom of the bioreactor to the top, 
thereby passing media, nutrients, and oxygen through the scaffolds for the attached cells. This 
design can be seen below in Figure ES2.  
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Figure ES2. Alternative Scaffold Bioreactor Design 
Packed Bed Bioreactor 
This design focuses on addressing cellular adherence in addition to volumetric efficiency 
with the utilization of a packed bed of microcarriers. The typical impeller system in the current 
Cytodex system is replaced with a continuous pumping mechanism, where the media 
continuously travels through this packed bed of microcarriers, so that cells that are unable to 
attach are looped back into the beginning of the system in an attempt to seed them onto the 
beads. The replacement of the impeller system helps to reduce shear forces and provides a 
method for nutrients and oxygen to be constantly delivered to cells seeded within the packed bed 
of microcarriers. The packed bed itself enables an increase in available surface area for cellular 
adherence since many microcarriers can be packed together within a smaller volume in 
comparison to the Cytodex system. In addition, cellular bead to bead migration is possible due to 
the dense packing of the microcarriers, further enabling confluency and cellular proliferation to 
achieve higher amounts of cell densities. This design can be seen below. 
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Figure ES3. Packed Bed Design 
Interlocking Microcarriers 
This design involved maintaining the current stirred tank bioreactor system that is utilized 
in the Cytodex system, while focusing on increasing the potential surface area for cellular 
adherence and proliferation through interlocking microcarriers. One main issue with the current 
Cytodex system is that there is a lack of bead to bead cellular migration, and as such 
microcarriers which were not seeded with cells initially will likely never be able to contain any 
cells since the attached cells are confined only to the bead they initially attached to. As such, this 
design incorporates the utilization of polarized glass beads, half of which are positively charged 
and the other half which are negatively charged. While the initial intermittent seeding method 
will still be utilized, as the microcarriers are mixed within the bioreactor, the polarized charges 
will enable the positively charged beads to become attracted to the negatively charged beads. 
This will increase the available surface area for the initial seeding phase, while also enabling 
cells to migrate between microcarriers, which will also increase the available surface area for 
cellular growth and confluency. 
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III. Final Design 
 The final design of our bioreactor system consisted of three major components: The 
reactor, a one-liter media flask, and a pump. The reactor itself consists of the outer reactor shell 
and a middle insert in which the beads are packed. The shell is comprised of two end pieces into 
which a borosilicate glass tube is press-fit and sealed with rubber O-rings. The end pieces are 
internally tapered to allow for even fluid distribution, and are connected to the larger system 
through nipple ports on either end. The middle insert is a hollow, cylindrical, double threaded 
tube with two steel meshes of 200-micron porosity on either end, which are secured in place by 
threaded caps containing rubber O-rings to create a watertight seal. The beads are packed 
between the meshes, and the insert is then placed within the glass tube before it is fit into the end 
pieces. This packed bed design is a significant component of the bioreactor system as it allows 
for large amounts of surface area to be achieved in smaller bioreactor volumes, making the 
system more volumetrically efficient. Additionally, cellular bead to bead migration will be 
promoted, thereby allowing for a greater utilization of the available surface area for cellular 
adherence.  
In order to allow for proper fluid exchange and media oxygenation, the one-liter media 
bottle is outfitted with a ChemGlassTM three port assembly cap, to which the reactor tubing will 
be connected. The pump used is an E-series Manostat Peristaltic Pump, with a non-adjustable 
flow rate of 56.8 milliliters per minute. This pumping mechanism will allow for reduced shear 
stresses in the system since it replaces the impeller system used in the initial culture process. In 
practice, the system is assembled with the media bottle and reactor being placed within an 
incubator, with the pump being connected externally through rubber stoppers placed through the 
incubator walls. The entire system is displayed in Figure ES4 below. 
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Figure ES4. Final Bioreactor system design 
 
IV. Results and Discussion 
We performed several verification tests including testing the fluid flow of our system and 
performing calculations to confirm that the shear stress created in the system is low and that the 
bioreactor is capable of supporting the oxygenation requirements of the cells. These results 
indicated that continuous flow is maintained within the system, and that the peristaltic pump with 
its constant flow rate of 56.8 mL/min is capable of delivering enough oxygen for the maximum 
possible number of cells in the system, while also generating shear stresses that are low enough 
that they will not negatively impact cellular morphology or behavior. After assembling the novel 
bioreactor system, a comparison study would have been run between a current state of the art 
adherent bioreactor and our novel bioreactor by running the two systems simultaneously for two 
weeks. Throughout the culture period, measurements of key nutrients and metabolites would 
have been performed to verify cell viability. A final cell density test would have involved image 
analysis to obtain comparative measurements of the cell concentration on the Cytodex and glass 
beads. The nutrient/metabolite assays would have determined the levels of Glucose, Glutamax, 
Glutamate, Lactate, Ammonia, and Lactate Dehydrogenase in the medium.  
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From the results of the static culture experiment, it would be expected to see bead-to-
bead migration in our bioreactor, which is not achieved in the current state of the art. This could 
have resulted in higher cell densities for the glass beads compared to the Cytodex. The expected 
result of the nutrient test is an exaggerated trend line for our novel bioreactor in comparison to 
the adherent intermittent stirring system. This variance would be due to faster nutrient depletion 
and waste generation that corresponds to the higher cell counts. Overall, we were able to achieve 
bead-to-bead migration in static culture, confirm continuous fluid flow of our system, and 
calculate a 6.5-fold increase of volumetric efficiency from our novel bioreactor system with the 
utilization of glass beads. 
 
V. Conclusions and Recommendations  
 Several objectives were met through the process of fabricating the final design and 
verifying its functions. First, bead to bead cellular migration was achieved within static culture, 
and as such this same result would be expected if translated into the packed bed bioreactor 
system. This would meet the objective of promoting maximum confluency by allowing cells to 
migrate onto microcarriers which previously did not contain any cells from the initial seeding 
process. Second, continuous flow was achieved within the bioreactor. This continuous flow is 
important because it would theoretically help to meet the objective of increasing attachment 
efficiency through the recycling of unattached cells within the closed-loop system. Third, 
volumetric efficiency was demonstrated with the novel bioreactor as calculations highlighted that 
our packed bed bioreactor achieves a 6.5-fold increase in volumetric efficiency in comparison to 
the Cytodex microcarrier system.  This is significant as it would allow for higher cell densities to 
be achieved in lower amounts of volume.  
 Going forward, several recommendations can be made regarding the design and 
functionality of the bioreactor. First, due to COVID-19 the team was unable to perform the 
suggested comparison study between the novel bioreactor and the current microcarrier system, 
and so this should be performed in order to compare the achievable cell densities. Additionally, 
the middle insert could be modified so that there is a see-through window within the design, 
allowing users to directly visualize the packed bed and ensure that it is stable. In terms of 
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optimizing the bioreactor design, it would be ideal to make the reactor incubator-independent 
like most current benchtop bioreactors. This would involve adding a thermal jacket for 
temperature regulation, an oxygen supply for proper culture oxygenation, and nutrient supply for 
the system. The reactor may also be modified to interface with process control sensors like 
current benchtop bioreactors so that temperature, pH, and oxygen can be directly measured. 
Additionally, the scalability of the bioreactor should be confirmed with the manufacturing and 
testing of larger-sized models to ensure that in the end, this bioreactor design will be capable of 
supporting larger biomanufacturing processes.  
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Chapter 1: Introduction 
The general need that is being addressed with this project is the design and functionality 
of bioreactors in the current biomedical industry, more specifically those engineered towards 
adherent cell culture. A bioreactor is a manufactured device that is able to support an 
environment that allows biological functions to occur. The main priorities are to support cell 
survival along with tissue structure, organization, mechanical properties, and function. The most 
fundamental principle of bioreactors is allowing robust cell growth at various densities by 
offering the ability to scale up or scale down in terms of working volume of cell media. With 
this, bioreactors can be utilized for specialized applications such as microbial fermentation and 
the production of biological molecules, such as vaccines, which require the functionality of 
healthy cells in order to be produced. This scale up process grants greater control and 
functionality in large-scale commercial manufacturing as well as in clinical trials and process 
development [1].  
As such, the optimization of adherent bioreactors is a significant aspect in improving 
yield and productivity. In terms of current bioreactors on the market, the micro-reactor scale is 
anywhere from 15 mL to 10 L and the large scale is typically 10,000 to 25,000 L; however, most 
of this is applicable only for stirred-tank bioreactors aimed towards suspension cultures. In many 
cases, each aspect of the reactor must change in order to accommodate larger volumes. Such 
components include the impeller, which is the primary stirring mechanism of a reactor. It 
typically consists of a set of blades attached to a motor that is capable of exerting the necessary 
force and rpm to thoroughly mix the bioreactor medium. Other components include the sensory 
systems which monitor pH, oxygen levels, and other nutrients, as well as gas exchange 
components which bubble essential gasses into the reactor chamber, and fluid flow paths which 
allow for nutrient and substrate exchange. The most important aspects of a bioreactor are the 
ability to provide proper oxygenation and nutrient exchange for the cells in the environment in 
order to maintain homeostasis and optimize their growth. Current bioreactor systems for 
adherent cells utilize microcarriers, small beads or disks which provide an attachment surface for 
adherent cells to anchor on, helping to increase their viability [2]. As such, when characterizing 
adherent bioreactor systems, attachment efficiency and cell viability are important criteria to 
consider. Unfortunately, upon interviewing with a client in the biomanufacturing industry, it was 
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highlighted that with current microcarrier systems in place, attachment efficiency is an issue due 
to the repeated shear forces applied during the culture setup which is capable of ripping cells off 
of the microcarriers. In fact with rabbit mesenchymal stem cells, certain microcarrier products 
have had as low as 16.7% of the total amount of inoculated cells attached to the microcarriers. 
And even with optimization of the attachment conditions, only an attachment efficiency as high 
as 65% was observed [3]. Improving these attachment efficiencies for adherent bioreactors 
would help to yield higher cell densities, and ultimately, increase the capabilities of 
biomanufacturing scalability.   
The overall goals of this project are to break down the design and operation of current 
adherent cell culture technology, and fabricate a novel design capable of increasing adherent 
efficiency and cell viability for the purposes of optimization with the potential for 
pharmaceutical and industry translation. In essence, this requires understanding the fundamental 
function of the bioreactor and its many physical and theoretical aspects that contribute to the 
fluid dynamics which govern mixing in the system. The design has to incorporate these 
multidisciplinary factors in order to generate a novel system capable of improving upon current 
microcarrier systems. After the creation of a specific design, this novel system will have to be 
tested in comparison to current microcarrier systems in order to determine whether the 
attachment efficiencies and total cell densities are improved in the experimental bioreactor. 
Another important aspect to consider as well is the potential for scalability. Many bioreactors in 
the biomanufacturing industry are designed so that operations on a bench-top bioreactor can be 
translated into a large-scale manufacturing process. As a result, the potential for scalability is a 
factor as well, as the design of this novel system must be streamlined enough so that it is 
reproducible on any scale.  
In order to complete the overall goals for this project, a general strategy was utilized 
which encompasses several phases of design and ideation. First, essential background research 
into literature about the design and functionality of bioreactors was conducted, especially in the 
context of adherent cell cultures. This knowledge on the fundamentals of bioreactor operation 
was then translated into a better understanding of current microcarrier systems on the market and 
their mechanisms for cell attachment. One of the key aspects was the fact the success of adherent 
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cells is dependent on oxygen and nutrient transfer, fluid flow, and the mechanical forces 
imparted by the flow.  
The next step was the design aspect of our project. Once thorough research was 
conducted, we started designing the bioreactor and its different components. This included 
prototyping with dimensions, materials, and the various components required to create a fully 
functional bioreactor capable of supporting cellular homeostasis.  
Once a design was chosen for prototyping, various verification experiments were 
performed in order to test cellular attachment and fluid flow. These were essential components 
which must be integrated into the bioreactor system to ensure that the adherent cells were 
capable of attaching, growing, and maintaining homeostasis without any disruptions. 
Verification of attachment was important as this established the type of materials which was used 
within the bioreactor. Meanwhile, the verification of fluid flow helped to ensure that proper 
laminar flow is imparted by the system so that shear stresses did not mechanically disturb the 
cells in the system. Optimization of these aspects ensured that the final design of the bioreactor 
was fully optimized. In order to actually test the final product, there were several metrics and 
benchmarks that were compared. Cellular growth and nutrient depletion curves were compared 
between control bioreactors and the experimental bioreactor. This was done in order to ensure 
that cellular function and viability was improved, if not at the very least not negatively affected, 
by the novel design. For example, the doubling time for human dermal fibroblast cells is 
approximately 24 hours, and so it is expected that these numbers either remain the same or are 
improved between the control and test bioreactor [4]. By utilizing these various metrics and 
benchmarks, the quality and feasibility of the team’s designed component could be assessed and 
analyzed.  
The succeeding chapters of this report will attempt to provide a detailed account of the 
MQP project. It will begin with a literature review in which the current state of the art of 
bioreactors will be identified and evaluated, its limitations analyzed, and potential modifications 
noted as key focal points of the design process. The report will then provide an overview of the 
project strategy in which the methods and timeline for the project will be laid out. This will be 
followed by an in-depth account of the design process, including a concrete set of design 
constraints, associated parameters, preliminary ideas, and the prototyping process. It will then 
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lead into the final design and validation, before carrying onto a discussion of the methods, 
procedures, processes, and performance of the final design. The report will conclude with a 
retrospective on the entirety of the project, while providing recommendations for future efforts in 
related fields.        
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Chapter 2: Literature Review  
2.1 Cell Culture and Bioreactors 
Bioreactors are commonly defined as a device in which biochemical processes occur 
where the process can be closely monitored and the environment is able to be tightly controlled 
and observed. They are often translated from benchtop production to industry use due to their 
ease of reproducibility. This reproducibility is made possible because the monitoring and 
automation control technologies are similar in both scales and must simply be replicated to the 
desired scale [5]. The bioreactor plays a crucial role in cell culture in order to provide an 
enhanced environment for tissues to thrive and grow [6]. 
Bioreactors allow for an environment in which cells are able to be cultured, which is why 
it is important for the seeding of these cells to be accurate and successful. There are a variety of 
ways in order for cells to be seeded in a bioreactor and the technique can affect the properties of 
various materials that may be used in the bioreactor [5]. There are two main varieties of 
bioreactors, which are known as stirred-tank bioreactor and packed-bed bioreactors. Stirred-tank 
bioreactors provide an environment where the cells are cultured while in suspension with a 
constant agitation due to an impeller. This type of bioreactor is constantly in motion, which can 
lead to effects of shear stress on cells. The constant motion allows for cells to flow freely in the 
agitated media, creating a homogeneous mixture of cells and nutrients. This type of bioreactor is 
typically used for non-adherent cells. The utilization of an impeller within the system disrupts 
the bubbles that are released from the air sparger in order to control dissolved oxygen in the 
system. Additionally, the impeller is typically set at a 45-degree angle in order to provide both 
radial and axial mixing, while the pitched blade decreases the shear stress that could affect 
sensitive cells [7]. 
The packed-bed bioreactor is a system in which cells are placed in an environment that is 
comparable to in vivo. The size and shape is similar to that of the stirred-tank; however, there are 
different mechanics in order to produce a homogeneous environment. The packed-bed system is 
typically used for adherent or anchorage-dependent cells. The packed-bed is able to provide 
protection of the adherent cells from the shear forces experienced in a bioreactor while 
simultaneously allowing oxygenated media to flow through the bed [7]. 
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There are three main categories of bioreactors in order for nutrients to be introduced and 
maintained in the environment. The first category is a batch system where cells remain in a fixed 
volume of media. In this system the nutrients introduced into the system are gradually consumed 
and as they are consumed, by-products begin to form. The environment is continuously changing 
due to the formation of by-products, and the media is not changed until the end of the entire run. 
This system is easy to operate and there is a low risk of contamination because there is no 
disturbance to the environment throughout the entirety of the process. However, the disadvantage 
is that these systems produce the lowest cell densities compared to the other two systems [8]. 
Fed-batch is slightly modified from the batch system and is very common in the 
bioprocess industry. In this system there is a set time for cells to grow and there are various 
increments of time where nutrients are added throughout the process. The culture is not collected 
until the entirety of the run similar to the batch system. Due to the fresh nutrients being added 
continuously, there is a large amount of biomass at the end of the run; however, because the cells 
are not being overfed there is not much by-product [8].  
Continuous bioreactor systems have fresh medium continuously added, while in parallel, 
used medium as well as cells are harvested. The volume is able to stay constant because the 
addition and subtraction of the same volume of medium occurs at the same time. Scale-up of this 
system is simple because the working volume remains constant. However, this system may 
introduce complications with sterility due to the constant addition and harvesting that may lead 
to exposure to the outside environment [8].  
Although there are various types of bioreactors, in the end the bioreactor system needs to 
be optimized so that shear effects are minimal, sterility is not compromised and cell densities are 
increased in order to achieve the highest possible efficacies.  
2.2 Adherent Cells - Process and Criteria 
Adherent cell culture is a rapidly expanding field for both research and commercial 
purposes. Adherent cells are especially important for tissue engineering applications, as the vast 
majority of organic tissue is composed of adherent cells. In nature, adherent cells grow and 
proliferate on complex biomaterial scaffolds composed of compounds and proteins which form 
the extracellular matrix. In culture conditions, the cells must be given an artificial, stable surface 
upon which to grow and proliferate.  
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In the biomanufacturing industry today, the vast majority of cell cultures involve non-
adherent cells that are cultured within suspension systems. This is due to the fact that the yield 
and survivability of adherent cells is limited by the available solid surface area within a culture 
or reactor. This introduces significant issues in terms of scalability and production efficiency. 
Additionally, many of the adherent cells desired for research and commercial purposes are very 
delicate and difficult to seed, culture, and harvest.  Such cell types include endothelial, skeletal 
muscle, and stem cells. Much of the current industrial and academic adherent cell culture interest 
revolves around stem cells, as they are self-renewing, have remarkable ability to differentiate 
into many different cell types, and have become a significant part in the generation of therapies 
for many diseases/illnesses [9]. Stem cells show promise in major advancements in the cell 
culture industry, however, they are associated with several difficulties. They are fragile, costly, 
and difficult to maintain in high volumes. With this said, a high cell viability and yield is a 
necessity in taking advantage of the cells’ shorter lifespans. 
  In order to increase cell viability and efficiency in the bioreactor, cells are attached to 
small microcarriers, which increases the total surface area cells are allowed to grow on. Cell 
adhesion in these systems is achieved through a long, tedious process. In this process, cells and 
microcarriers are mixed together into a homogeneous mixture. The mixing inside the bioreactor 
is then turned off, allowing all products inside the bioreactor to settle to the bottom. Cells then 
are given time to adhere to the microcarriers. The time given to the cells to allow them to adhere 
to the microcarriers differs depending on cell type.  
 The difference in adhesion time can be contributed to the extracellular matrix (ECM) of 
the cell. The ECM of a cell contains many different adherent molecules and peptides. These 
molecules are typically negatively charged, allowing them to adhere easily to positively charged 
surfaces [10]. Cellular adherence is the process in which cells are capable of interacting with 
these external biomolecules through focal adhesion complexes (FACs), large transmembrane 
protein complexes that allows the cytoskeleton of a cell to connect to the extracellular matrix. 
These FACs typically involve integrins on the cell surface. Adherent cell culture aims to promote 
this attachment in order to support adherent cells. For example, a protein commonly found in cell 
culture media is fibronectin, which is capable of binding integrins and FACs. In media, these 
proteins are capable of coating cell culture surfaces, enabling cells over time to adhere and 
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slowly spread out [11]. The timing of adhesion depends on how quick the cell can extend their 
ECM and adherent molecules onto the point of attachment.  
 Once the cells are given time to adhere, the mixing is turned back on and the process is 
repeated many times in order to cover as many microcarriers as possible with cells. During re-
agitation, and mixing, cells experience shear stresses from the media being passed by. These 
shear stresses can cause cells to detach from the microcarriers rendering the cells useless during 
after that time. This is a widely used process and has been said to be inefficient by researchers 
due to the time it takes and the overall low cell adhesion associated with it. 
2.3 Current Microcarrier Systems and Materials 
In today’s market, one of the largest trends in the biotechnology industry is the 
development and optimization of cell culture technologies in order to produce the highest 
possible yield, whether this is cells or products made from cells, at the lowest possible labor and 
financial costs. In terms of adherent cells, mammalian cells are commonly used in industry, 
however, it should be noted that most animal cells typically have lower yields in comparison to 
other types of cells. As such, larger culture volumes are typically required in order to produce 
higher amounts of product, while scale up is difficult for adherent cells in traditional culture 
plates. Due to this, the utilization of microcarriers have been developed, creating a practical, 
high-yield culture of adherent cells, enabling higher cell densities to be accommodated in lower 
amounts of volume [12]. By increasing the capabilities for production while requiring less space 
than typical monolayer cell cultures, microcarriers provide a more efficient adherent cell system 
and enable lower labor costs.  
Microcarriers are designed as spherical, micrometer-sized carriers wherein adherent cells 
are capable of adhering and forming monolayers. These carriers typically range in diameter from 
10 μm to 5 mm, with the ideal size being considered as 100 to 300 μm [12]. Other forms of 
microcarriers come designed with pores, thereby enabling cellular penetration and theoretically a 
higher surface area for more cell adherence. There are some challenges associated with porous 
microcarriers, however, such as the increased difficulty of cell harvesting [13]. Microcarriers are 
often utilized in stirred suspension bioreactor or micro reactor systems, as stirring enables a 
homogeneous culture environment around the carriers, ensuring that cells are uniformly getting 
proper aeration and nutrients while also disrupting any microcarrier aggregation that may occur. 
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These culture systems can include cultures with a constantly stirring impeller, shaker flasks on 
rocker platforms, or with smaller flasks, a magnetic stirrer system to drive the impeller [13]. One 
limitation with microcarrier systems is the fact that it is slightly harder to quantify the cell 
density and the number of viable cells, as this would involve having to detach the attached cells, 
which would not be ideal until the end of the culture process. As such, there has been the 
development of indirect quantification techniques which involve measuring metabolic activity 
markers, such as glucose consumption or lactic acid production, or the concentration of enzymes 
such as lactate dehydrogenase [13].  
Various materials are utilized for microcarriers, ranging from natural polymers such as 
collagen and dextran to synthetic plastics and silicone rubber or even glass. Currently on the 
market, one of the biggest sources of cell culture microcarriers is GE Healthcare with their 
Cytodex microcarriers. One product, the Cytodex 1 microcarrier, is made from cross-linked 
dextran, is positively charged, and has an average diameter of 190 μm [12]. One promising 
alternative to the utilization of natural polymers is glass, as much research has focused on 
demonstrating comparable results between glass carriers and dextran or plastic microcarriers. 
Glass has already been researched as a promising cell culture substrate, with the material now 
being utilized in various cell characterization processes such as centrifugation assays to 
determine attachment strengths [14]. As such, the transition to microcarriers is not an unexpected 
development. Although there is currently not a glass microcarrier product out on the market, 
much research is being conducted to examine its feasibility and potential advantages in 
comparison to polymer-based systems, with one study demonstrating the biocompatibility and 
feasibility of facilitating controlled cell growth on glass microcarriers [15].   
In terms of the optimization of microcarrier culture, one of the most important aspects is 
the beginning stirring process involving the attachment of the cells onto the carriers. The typical 
process utilized in the industry currently is an intermittent stirring process, which involves 
culturing the cells and microcarriers at a slightly lower volume than the final intended volume. 
Afterwards, stirring through the impeller will occur over a small period of time at frequent 
intervals, with “down periods” in between each stirring session where the microcarriers and cells 
will settle to the bottom of the culture. These “down periods” enable the cells to physically attach 
to the microcarriers, while the stirring phases help to ensure homogeneity in the environment 
[13]. Once the attachment process is completed, continuous stirring will occur as normal in a 
10 
 
stirred culture system, although the specific culture process and impeller parameters will depend 
on the cell line.  
2.4 Current Limitations 
 Several limitations exist with the current adherent bioreactor system that utilizes Cytodex 
microcarriers in conjunction with an intermittent stirring process. First, research has found that 
the utilization of these microcarriers generally leads to low attachment efficiencies. For example, 
research with rabbit mesenchymal stem cells demonstrated that GE Cytodex microcarriers have 
had as low as 16.7% of the total amount of inoculated cells attached to the microcarriers. Even 
after further optimization of the attachment conditions, only an attachment efficiency as high as 
65% was observed [3]. Attachment efficiency is an extremely important parameter within 
adherent cell culture because it is desirable to maximize the amount of cells capable of attaching 
and proliferating within the bioreactor system when the system is inoculated. Having low 
efficiencies will result in a waste of resources due to large amounts of cells dying and not being 
utilized due to the inability to adhere onto the substrate within the system. In the end, this will 
result in economic loss as well as the need to utilize larger bioreactor systems to achieve certain 
final density yields when smaller systems could potentially be used instead if the attachment 
efficiency was higher. 
 This limitation is corroborated when interviewing Chris Bellerive from WPI’s 
Biomanufacturing and Education and Training Center. Our interview with Chris can be found in 
Appendix A: Interviews with Chris Bellerive. Essentially, Chris highlighted that low attachment 
efficiencies are typically observed, and a large reason for this is the amount of shear stresses 
generated during the intermittent stirring process. Additionally, although the stirred tank system 
enables homogenous mixing of microcarriers in the media, this constant stirring creates dead 
space within the system so that it is extremely difficult for microcarriers to come into contact 
with one another. Due to this, there is a lack of cellular migration between microcarriers, and so 
microcarriers that were not initially seeded with cells will not be able to support any cells since 
they are all confined to the initial microcarriers they were seeded on. This is a reason why the 
current adherent bioreactor system is volumetrically inefficient. Chris highlighted as well the 
long process of the initial culturing stage, where the intermittent stirring process is time-
consuming and requires constant manpower to operate and monitor. As such, a potential need to 
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be examined is the development of an enhanced bioreactor system aimed at increasing the 
overall attachment efficiency in order to better optimize the cell culture process. Doing so will 
allow for larger cell densities to be achieved with smaller bioreactor volumes, helping to 
decrease the time and labor costs associated with bioreactor operations. 
2.5 Surface Modifications 
 When examining and optimizing adherent cell culture, an important factor to consider is 
the promotion of cellular attachment within the system. Various techniques have been studied 
and well-characterized in the optimization of cellular adherence in order to improve cell 
densities. One such technique is the utilization of oxygen plasma treatment in order to increase 
cell adherence. Plasma treatment is considered a “cleaning” technique where a gas is electrically 
charged with electrons moving freely, resulting in a partially ionized state. The mixture of atomic 
and molecular ions, neutral atoms, and electrons can interact with a surface, thereby initiating the 
plasma treatment. Studies have focused on the utilization of oxygen plasma treatment in the 
promotion of cellular adherence. For example, this technique has demonstrated the ability to 
modify the surface properties of Polydimethylsiloxane (PDMS), a common silicone-based 
polymer that is commonly found in microfluidic cell culture. More specifically, the application 
of oxygen plasma treatment changed the surface properties of PDMS to become more 
hydrophilic when its surface is typically hydrophobic [16]. This surface modification is 
important as it has demonstrated the promotion of increased cellular adherence and growth on 
silicone surfaces, making it a potential technique to be considered when optimizing adherent cell 
cultures [17]. 
 Another surface modification that has been characterized is the utilization of collagen as 
a surface coating to promote cellular adherence. Collagen is one of the most abundant proteins 
associated with the extracellular matrix in vivo, making it an excellent candidate to be examined 
due to its natural role in cellular adherence through cell-surface interactions. More specifically, it 
has been demonstrated how collagen surface coatings can be utilized in the modification of 
surfaces in order to promote high levels of cell attachment, proliferation, and even survival when 
the cells are subjected to stress [18]. The utilization of ECM protein coatings is an important 
modification to be considered when optimizing culture conditions for maximal cell adherence.  
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 Furthermore, gelatin coating is another cost-effective method to increase cell adherence, 
as it binds ECM proteins such as fibronectin quite effectively, as well as mimics the pliable 
surfaces that adherent cells grow on in nature [19]. Additionally, gelatin is an abundant, naturally 
occurring material, making it highly biocompatible, and as a result, it is commonly used for 
surface treatment in laboratory adherent cell culture. Its most common applications typically 
involve endothelial cell culture; however, it is expected that it can facilitate the growth of a wide 
variety of adherent cells [20]. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13 
 
Chapter 3: Project Strategy  
The goal for this project is to design a novel bioreactor system capable of increasing adherent 
efficiency and final cell densities. In this chapter, the client statement will be broken down into 
various objectives, design requirements, and specifications to guide the fabrication process of the 
novel system. Afterwards, the project strategy and timeline will be discussed. 
3.1 Initial Client Statement  
The initial client statement that was given to the MQP team was to design one aspect of a 
micro-bioreactor that will be used for rapid screening and process optimization and development 
activities. As shown, this initial statement is open-ended and vague, with no specifics in terms of 
what aspects or components of the bioreactor to focus on for technological improvement. In 
addition, there is no specification on the end objective of the team’s design besides potentially 
being utilized in optimization and process development. As such, this will require the team to 
conduct background research into the fundamental bioreactor processes and their utilization 
within industry in order to gain a better perspective and scope in developing project objectives.  
3.2 Design Requirements 
This section will discuss the design objectives, constraints, and specifications regarding the goal 
to increase the cellular attachment and final cell densities of adherent bioreactors.  
3.2.1 Design and Project Objectives 
Given the initial client statement, literature review and background research with industry 
experts was conducted in order to understand the current limitations within bioreactor systems. 
The team decided to focus on adherent bioreactor systems and their limitations, as discussed in 
Chapter 2: Literature Review. More specifically, the overall goals for this project are now to 
fabricate a bioreactor design capable of increasing adherent efficiency and optimizing the 
necessary bioreactor system so that smaller volumes can be utilized. A revised client statement 
embodies these new goals, as detailed in Section 3.4 Revised Client Statement.  
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As such, several design objectives can be identified which captures the general scope of 
the project and its goal to contribute to the technical improvement of adherent bioreactor 
processing. These main objectives are listed below. 
 
List of Design Objectives 
1. Improvement of cellular attachment on the bioreactor substrate  
2. Improvement of the bioreactor’s volumetric efficiency  
To further expand on these, the first main objective details how the design must be able 
to improve seeding efficiencies in comparison to the current microcarrier technology, which in 
turn will allow for higher final cellular yields. The second main objective is to address the issue 
of surface area being the limiting factor within adherent bioreactors, thereby creating a system 
that is volumetrically efficient so that higher cell densities can be achieved in smaller bioreactor 
volumes.  
 The process for meeting the needs of the client and achieving the design objectives can 
be accomplished through several project objectives which encompass the entirety of the project 
from ideation to fabrication and experimental verification. A list of the project objectives is 
presented below. 
 
List of Project Objectives 
1. Determine best microcarrier material for cell attachment 
2. Verify shear stresses, oxygenation mechanisms, and volumetric efficiency 
3. Develop strategies to fabricate a functional device 
4. Test functionality and compatibility of novel design in comparison to current adherent 
system 
First, the team determined the best microcarrier material on which the cells inside the 
bioreactor system will adhere to throughout the entirety of the process. This aspect consisted of 
testing various materials as surfaces for the cells to adhere to, as well as various surface 
treatments on the material to obtain successful cell seeding. This objective is important because 
the adherent cells require proper attachment to a surface during the cell culture process in order 
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to avoid cell death. In order for the cells to grow in the environment they must be adhered to 
some material and not free-floating in suspension, and so optimization of the microcarrier 
technology helps to improve cellular attachment and the maximum number of cells supported by 
the system. Additionally, the current bioreactor process involves an intermittent stirring process 
that requires manpower and must be monitored. The process is not only time-consuming, but 
could potentially cause problems due to the inherent shear stresses of the intermittent stirring that 
could rip off any adherent cells from the microcarriers, thereby reducing the attachment 
efficiency and the number of cells capable of growing and proliferating in the bioreactor. 
Increasing the attachment efficiency involved understanding the intermittent stirring mechanism 
and potential alternatives that would help to achieve proper nutrient and oxygen distribution 
while mitigating the potential for cell detachment during the culture process.  
Afterwards, oxygenation within the novel system needed to be verified using various 
equations that proved proper oxygenation of the cells is achieved in this environment. In 
addition, the shear stresses imparted within the system needed to be verified to ensure that they 
are not large enough to negatively impact the cells or detach them from their surface. These 
systems needed to be validated before the system was built in order to ensure that it would 
function properly. Additionally, the bioreactor system needed to be characterized in terms of the 
possible number of cells supported per unit volume, as this is indicative of volumetric efficiency.  
Third, strategies needed to be developed in order to fabricate a functional device. This 
involved research into the types of materials typically utilized in bioreactor systems and those 
which are biocompatible, meaning that they are not cytotoxic and do not induce any cellular 
death upon interaction with the cell culture. Finally, the final design will be tested within the 
bioreactor setting in comparison to the current adherent system in order to test its functionality 
and gain quantitative data on its impact on cellular growth or viability. This is an important 
objective because it will highlight if the novel design created by the team was capable of 
improving the adherent cell culture process in the context of bioreactors by streamlining the 
culturing process and enhancing attachment efficiency. These objectives provided a general 
framework for the team to work within, as accomplishing each goal put the team one step closer 
towards the final design and validation of the final product. 
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3.2.2 Design Constraints  
When designing our novel bioreactor there are a few constraints that we must abide by 
that alter the process of our project. These can be broken down into two separate categories: 
incubator-based constraints and pump-based constraints. In terms of incubator-based constraints, 
this reactor must be able to function within an incubator as the incubator is the main source for 
maintaining the environmental conditions which support cellular homeostasis. Although the 
bioreactor may be designed in the future to be incubator-independent, currently the design will 
be incubator-dependent in order to forgo the utilization of a bioreactor process controller. As 
such, the bioreactor must be able to fit within the 18 inches of shelf space in the incubator 
provided to the team in Goddard Hall 006. Additionally, this incubator must have specific 
conditions in order to support fibroblast cells in the reactor. This includes maintaining 
environmental conditions at a temperature at 37℃ ± 0.5℃, 5% ± 0.5% carbon dioxide levels, 
and a humidity greater than 90%.  
Additionally, the bioreactor design will have constraints due to the pump which will be 
utilized in the designs (this pumping mechanism and rationale is expanded upon in Section 4.2.1 
Conceptual Design Modifications). The pump that is used must be maintained outside of the 
bioreactor due to the high humidity which may be capable of interfering with the pumping 
system. Additionally, the pump to be provided is non-adjustable and set to a constant flow rate of 
56.8 mL/min. Therefore, the final design must work within these constraints in order to ensure 
that the novel system is capable of running and ensuring the cells in the bioreactor are able to 
grow and proliferate. 
According to the Worcester Polytechnic Institute MQP guidelines, each team receives a 
budget of two-hundred and fifty dollars per team member. This makes our total budget one 
thousand dollars to complete our project task. Another constraint that we have is time. All MQPs 
must be completed by the end of the academic year so we must finish our project by May 2020.  
3.2.3 Functional Blocks 
The components of an adherent bioreactor can be broken down into various functional 
blocks, each representing a specific operational aspect of the bioreactor cell process which 
contributes to its success. First is the aspect of cell attachment, which is essential for any 
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adherent culture since these specific cells require a substrate to adhere onto in order to properly 
grow and proliferate. In the current adherent systems, microcarriers accomplish this by providing 
a potential surface for cellular anchorage. Another important facet of cell attachment is the 
process with which this occurs as well. As described in the literature review, the current process 
entails intermittent stirring to allow cells to settle onto a bottom layer of microcarriers before 
being mixed. This process is essential to cellular attachment, and thus modifications to this will 
potentially impact the efficiency of cellular adherence. 
Another functional block to be considered is cellular confluency. Once the cells are 
seeded onto the microcarriers, their confluence on the beads will help to determine final cell 
densities and viabilities. Ideally, all microcarriers within the system would be 100% confluent, 
allowing for the maximum possible number of cells based on surface area. Unfortunately, not all 
beads once harvested achieve 100% confluency in the current Cytodex system. In fact, many 
beads do not contain any cells at all due to the fact that cells were unable to be seeded onto them 
during the initial seeding process. With confluency being inherently related to the final cell 
densities, modifications can be made to help improve this, such as increasing potential surface 
area for cellular attachment or enabling a process of bead to bead migration, where cells are 
capable of growing and dividing from one microcarrier onto another.  
Both of these functional blocks will be considered during the initial ideation process 
since modifications can be made to any of these components in an attempt to improve overall 
adherent cell culture performance. 
3.2.4 Design Functions and Means 
When creating our bioreactor, it is important to consider a variety of design functions 
inherent to the functional blocks described above in Section 3.2.3 Functional Blocks to ensure 
the success of the product. Table 1 presents a Design Functions-Means table and the content of 
this chart will be discussed in the following paragraphs. Since bioreactors directly interact with 
living cells, the materials and design of its components need to be biocompatible and promote 
the growth of these cells. In order to do this, our design must be able to replicate the many 
functions of a bioreactor without interfering with the typical systems in place that ensure cell 
homeostasis.    
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 One function our design must be able to achieve is the delivery of nutrients to the cells in 
the system. This can be achieved by making sure the mixing process produces a homogeneous 
mixture where the medium can flow through all the cells constantly which ensures the proper 
distribution of nutrients and gases. This type of mixture and flow can be made possible by 
utilizing an impeller like the current Cytodex system, introducing a pumping mechanism that 
will pump the media through the bioreactor, or modifying the bioreactor vessel shape to enhance 
homogeneous mixing. Oxygenation is another function that needs to be considered, as enough 
oxygen must be provided to support the growth of the cells. Currently this is accomplished in the 
Cytodex system with the combination of an oxygenator and an impeller to distribute the oxygen. 
However, other methods to accomplish this may include a pumping mechanism where media is 
pumped into the bioreactor already containing the dissolved oxygen, or a continuous perfusion 
system can be used instead where fresh media containing dissolved oxygen is constantly 
supplied into the system.  
Another function is the maintenance of the proper biological conditions for the cells in 
the bioreactors. In order to achieve this, a sterile environment must be maintained during all 
times. Many sterilization processes can be utilized to sterilize the environment before actual 
operation, such as autoclaving the bioreactor and its components, using radiation, or chemical 
means. In order to keep the device sterile over a period of time during its operation, O-rings and 
filtration systems can be utilized, in addition to using sterilizable materials in the design of the 
bioreactor system. Another function that the design must accomplish is to avoid introducing any 
toxicity to the cells in the bioreactor. This can be achieved by using biocompatible materials or 
by using biocompatible coatings on the materials chosen. Another aspect that needs to be taken 
into account is the stress imparted on the cells during the seeding process. Our bioreactor must 
be able to properly seed cells without inducing any additional stresses as this can negatively 
affect cellular behavior or cause the cells to lyse. The current Cytodex system utilizes an 
intermittent method, while other potential alternatives include a static method where the 
bioreactor system is shut down for a time period so that cells will be allowed to slowly settle 
onto the substrate, or a perfusion method that involves continuous movement of cells in media 
over the cell culture surface. 
 Lastly, our bioreactor system must be able to support cellular adherence. This can be 
accomplished with the utilization of microcarriers, although other alternatives which may 
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increase surface area include a packed bed design and the use of scaffolds within the reactor. The 
substrate material can also be modified, with potential materials including Dextran like the 
current Cytodex microcarriers, borosilicate glass and polystyrene.   
  
Table 1. Design Function-Means Table  
Design Functions Potential Means 
Fluid flow & Nutrient 
Distribution 
Pumping Impeller Vessel shape 
Oxygenation Continuous perfusion Stirred system w/ 
oxygenator 
Pumping 
Homeostasis Biocompatible 
materials 
Biocompatible coating Incubator 
Compatible 
Seeding method Static method Intermittent method Perfusion 
system 
Sterility maintenance O-rings Filtration Threading 
Connections 
Adherent Cell Culture Microcarriers  Scaffold Packed Bed 
Adherent material Cytodex (Dextran) Glass (borosilicate) Polystyrene 
 
3.2.5 Design Requirements and Specifications 
 The novel bioreactor designed by the group must meet certain design criteria and 
specifications in order to function and fulfill the client’s needs. All the design requirements are 
listed in Table 2 below and will be discussed in more detail in the succeeding paragraphs.  
First and foremost, since a bioreactor system is meant to maintain an optimal cellular 
environment for homeostasis, the novel bioreactor must be able to fit within an incubator capable 
of providing the necessary temperature and oxygenation for the cells in the bioreactor. Current 
bioreactor systems utilize their own self-modulating temperature and oxygenation functionalities 
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to fulfill this requirement, however the novel bioreactor design will likely be unable to 
incorporate these same functionalities, and thus must rely on an incubator for temperature and 
oxygen control. As a result, the bioreactor must work within the confines of the incubator. The 
current incubator in Goddard Hall 006 was measured to have approximately 18 inches of 
working space, and so the bioreactor must not exceed this height in order to properly fit within 
the incubator environment. Additionally, it cannot introduce unintended mechanical forces on a 
large scale that would disrupt the attachment process of the adherent cells and rip them off of the 
microcarriers, or affect their morphology or health. Studies have indicated that with Human 
Endothelial Kidney (HEK) cells, a common adherent cell line, shears above 6.5 dynes/cm2 may 
have an effect on orientation and morphology, while higher levels of shear such as 26 dynes/cm2 
will detach the cells from their surface and negatively impact cellular viability. Additionally, it 
has been found that the metabolism of HEK cells are affected by shear stresses as high as 6.5 
dynes/cm2, while the metabolism of human umbilical vein endothelial cells (HUVECs) are 
influenced by stresses at 10 dynes/cm2 [21]. As such, this range of 6.5-10 dynes/cm2 will be the 
upper limit for the shear forces imparted by the novel bioreactor design.  
Another key design requirement is reusability. The bioreactor must be reusable, and 
therefore sterilizable with ease. It must withstand a variety of sterilization methods, from 
chemical to high temperature (autoclave) sterilization. For this reason, the bioreactor and its 
components must be designed from a relatively inert material that is able to maintain its structure 
at temperatures well over 121℃, which is the temperature at which autoclaving processes 
operate. These specifications will allow the bioreactor to withstand multiple cycles of use and 
sterilization before they may need to be replaced. Afterwards, this sterility must also be 
maintained. This involves creating an air-tight, closed environment so that contamination can be 
avoided.  
Furthermore, the component must be biocompatible with a wide variety of cell types in 
order to maintain a high degree of versatility. It cannot be toxic, or otherwise chemically harmful 
to the cells in the bioreactor, while remaining non-degradable as to avoid contaminating a cell 
culture with material particles. In addition, the design should not interfere with the typical 
maintenance of homeostasis the bioreactor provides for the cell culture. For example, 
mammalian cell lines are generally maintained at temperatures of 37 ± 0.5 °C, while providing 
dissolved oxygen levels of 5% ± 0.5% CO2 and cell viabilities greater than 90%. In the end, the 
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most important condition that needs to be considered is the biological conditions of the cells and 
their productivities, which is influenced by many bioreactor aspects such as fluid flow and 
process control. These design requirements are summarized in Table 2 below. 
 
Table 2. Design Requirements 
Design Requirement Value or Attribute 
Work within incubator 18 inches in height 
Must not introduce significant mechanical 
forces 
Low shear stresses on microcarriers (limit 
of 6.5-10 dynes/cm2) 
Compatible with adherent cell culture Observed cellular attachment within system 
Must be reusable Easy to sterilize (must be able to withstand 
autoclave temperatures of at least 121 °C) 
Maintain biological conditions for cells Mammalian cell lines - 37 ± 0.5 °C, 5% ± 
0.5 % CO2 , > 90% humidity 
Scalability Design allows for functional fabrication of 
different-sized bioreactors 
Sterility Maintenance  Air tight, Avoid contaminations 
Compatible materials  Non-toxic, non-degradable, biocompatible 
 
3.3 Design Standards 
When designing the bioreactor system, it was important to consider the following 
standards/regulations when it comes to working with bioreactors and living cells. These 
standards are essential in determining the possible ways to achieve our goal and also in 
determining the success of the final design. A summary of the standards considered with the 
fabrication of the novel bioreactor are shown in Table 3 below: 
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Table 3. Summary of Standards Considered in Design 
ISO 11737 Sterilization of Medical Devices: Microbiological Methods, Part 1 
— Determination of a Population of Microorganisms on Products 
ASTM F1980:2007 Standard Guide for Accelerated Aging of Sterile Barrier Systems for 
Medical Devices 
ISO 13845:2016 Medical devices - Quality management systems - requirements for 
regulatory purposes 
ISO 10993-5:2009 Biological evaluation of medical devices — Part 5: Tests for in vitro 
cytotoxicity 
FDA 21CFR866:2018 Title 21,  Subchapter H, Part 866 - Cell and Tissue Products 
 
The first standard that should be considered is ISO 11737 (Sterilization of Medical 
Devices: Microbiological Methods, Part 1 — Determination of a Population of Microorganisms 
on Products) [22]. Sterility is extremely fundamental for the operation of a bioreactor as 
contamination must be avoided before the bioreactor is inoculated with cells. As such, the 
sterility of our novel bioreactor will be in accordance with this standard [22]. The team plans to 
design the bioreactor system so that it is reusable, and so it must be sterilized in between uses. 
This standard will be used to determine the sterility of the bioreactor from use to use. The 
standard establishes the requirements for validation and control of sterilization, such as how to 
determine whether or not the reactor is sterile. If the bioreactor contains the same amount of 
microorganisms on it as before sterilization it is considered not sterile and must be re-sterilized 
and checked again. 
 The second standard that should be considered is ASTM F1980:2007 (Standard Guide for 
Accelerated Aging of Sterile Barrier Systems for Medical Devices). This standard will be used in 
terms of the sterility of the barrier system in the bioreactor [23]. It is essential that sterility is 
maintained over a prolonged period of time, as bioreactor operations can range from days to 
weeks. This standard addresses the accelerated aging theory, in which properties may change 
over time, affecting the proper function of a sterile barrier system. As stated previously, it is 
essential to ensure that the inside environment of the bioreactor is sterile when in use and no 
contamination will occur.  
The third standard that should be considered is ISO 13845:2016 (Medical devices - 
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Quality management systems - requirements for regulatory purposes). The design of the novel 
bioreactor must be in accordance with this standard [24]. This standard provides guidelines 
throughout the entire design process, from ideation to prototyping and final design fabrication, in 
order to ensure that the product’s function and quality sufficiently meets the client’s 
requirements. The product must function the way it is intended and accomplish all parts of the 
revised client statement. As such, this standard is relevant to the design process.  
The fourth standard that should be considered is ISO 10993-5:2009 (Biological 
evaluation of medical devices — Part 5: Tests for in vitro cytotoxicity) [25]. This standard will 
be useful in determining the toxicity of a material, as it specifies various types of tests that can be 
performed in order to determine whether or not a material is toxic to cells when in use. This 
standard is important because the bioreactor cannot introduce toxicity to the cells, as this would 
compromise the function of the cells and the operation of the bioreactor. 
 The fifth standard that should be considered is FDA 21CFR866:2018 (Title 21, 
Subchapter H, Part 866 - Cell and Tissue Products) [26]. These standards/regulations will be 
used when it comes to testing the bioreactor with live cells. These regulations help to define and 
specify many parts of the cell culture process such as culture medium, quality control kits, and 
microbial monitoring, which will be important in the operation and testing of the bioreactor 
system.   
3.4 Revised Client Statement 
After conducting further research and developing the objectives for this project so that it 
is more reflective of the issues relating to cellular yields in biomanufacturing, the client 
statement was revised. The updated statement now states to design a novel bioreactor system, 
which allows increased cell viability and attachment efficiency compared to those from current 
adherent bioreactor designs. As shown, the project will now focus specifically on creating a 
novel bioreactor system and how cell viability can be increased, specifically through the use of a 
packed bed microcarrier system. In the end, this novel reactor will help increase cell viability and 
attachment efficiency of cells in microcarrier systems. 
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3.5 Management Approach 
During a project, it is important to set a variety of different milestones. Creating such 
milestones will help us understand the important steps needed in order to design and create a 
final product and to ensure the completion of the project in a timely manner. The major project 
milestones for this project are as follows: 
➔ Undergo and complete necessary background research into bioreactors (August 2019 - 
October 2019) 
➔ Define and state clear project objectives (September 2019 - October 2019) 
➔ Complete the first four chapters of the MQP report (September 2019 - October 2019) 
➔ Conduct a series of client interviews in order to gain a clearer understanding of the 
practical industrial applications of bioreactors (October 2019 - November 2019) 
➔ Continue conducting client interviews to focus on specifics of adherent bioreactors and 
current industrial needs (November - December 2019) 
➔ Begin designing initial concepts of novel bioreactor system (January 2019 - February 
2020) 
➔ Conduct initial validation tests before manufacturing final design (February - March 
2020) 
➔ Finalize manufacturing of final novel bioreactor design (March 2020) 
➔ Conduct necessary at-home experiments to validate functions of experimental bioreactor 
(March - April 2020) 
➔ Finalize MQP report and Present the results of the MQP Small Scale Bioreactor project 
(May 2020)  
 
These milestones and events can be summarized utilizing a Gantt Chart as shown in Figure 1: 
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Figure 1. Gantt Chart for Project Timeline 
 
 Major Qualifying Project teams at WPI receive a set budget for their projects. This 
project has a set budget of $250 per student on the team. Since our team has 4 members, the total 
budget for this project is $1,000. Any amount over this has to be paid for by the team itself.  
When designing the bioreactor system, it is important to remember this budget when buying 
materials, creating the bioreactor and its components, and testing it. 
 When designing our bioreactor, we must consider the possible materials to be used and 
the cost of those materials. Some of the possible materials we plan to use are listed in Table 4: 
Cost of Potential Materials. The potential costs of these items were found using the CES 
Edupack software provided to us by WPI. 
 
Table 4. Cost of Potential Materials 
Material Cost (USD) 
316L Stainless Steel 5.77-6.35 per kg 
Borosilicate glass 4.49-7.48 per kg 
Low Density Polyethylene 1.61-1.65 per kg 
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Chapter 4: Design Process 
Chapter 3 specified the design objectives, constraints, functions-means, and specifications of the 
final design in order to fabricate the system according to the requirements and goals. This 
chapter will break down the design needs and evaluate the initial designs to determine which 
design best satisfies these requirements.  
4.1 Initial Concept Map 
 When the team first received the initial client statement, we began to brainstorm ways in 
which we would be able to improve bioreactor usability in terms of streamlining the operations 
to improve efficiency in the context of resources and time. Below is the concept map that 
summarizes the initial concepts thought of by the team that would be able to achieve improving 
efficiency, such as by reducing the instances of contamination, improving the longevity of the 
bioreactor when it is in use, reducing the set up process so that it is less time-consuming, creating 
a system that would be able to reduce the shear forces in the bioreactor, and increasing cellular 
adherence.  
 
 
Figure 2. Concept Map 
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Once the team further consulted Chris Bellerive, we had learned that a major issue with 
bioreactors is the efficiency of adherent bioreactors in the context of cellular adherence and 
volumetric efficiency. This resulted in the team brainstorming various functions that the 
bioreactor must have, as well as means to achieve these functions, as described in Section 3.2.4 
Functions and Means, and design requirements and specifications, as described in Section 3.2.5 
Design Requirements and Specifications. Afterwards, we broke down the design requirements 
into specific needs and wants, as described in the next section.  
4.2 Needs Analysis 
The design requirements for the improved bioreactor system can be broken down into 
“needs” and “wants”. These needs and wants can be found in Table 5 below: 
 
Table 5. Summary of Needs and Wants 
Needs Wants 
Non-disruptive to cells Ease of Manufacturing 
Volumetric Efficiency Scalability 
Sterilizable Ease of Culture 
Promotion of Maximum Confluency  
 
The first need involves the mechanical forces imparted on the cells during the culture 
process. This need encompasses analyzing the potential seeding methods and fabricating an 
improved system over the intermittent impeller stirring method that does not detach cells or 
negatively affect their behavior. As such, in terms of maintaining negligible impact on cell 
attachment and viability, the fluid flow should remain homogeneous, with laminar flow 
dominating rather than turbulent flow which could impart shear stresses on the cells. Although 
Reynold’s number may be utilized to characterize the fluid flow, a more significant 
characterization is the shear force that is imparted on the cells. The designs specification outlined 
in Section 3.2.5 Design Requirements and Specifications provides an upper limit of 6.5-10 
dynes/cm2 that must be incorporated into the design.  
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Another need is that the design must be volumetrically efficient, meaning that it is 
capable of supporting larger numbers of cells in a smaller volume. As such, the final design 
would ideally be small enough to be portable, and would not require extensive manpower or time 
to start up and run the system. As mentioned previously, the current Cytodex system requires 
extensive labor and time due to the fact that it is not volumetrically efficient and requires an 
intermittent stirring system. Our design must consider this aspect so that in the end the bioreactor 
operations are physically streamlined.  
Additionally, the materials chosen for the bioreactor system must be sterilizable in order 
to support homeostasis of the cells. Inherently, the materials chosen must also be biocompatible, 
so that after being sterilized a completely sterile environment is created that enables cells to 
properly grow and proliferate without being negatively affected. This signifies that in accordance 
to ISO 10993, the material that is utilized for the bioreactor should be classified with a cytotoxic 
grade of 0, indicating that there is no cell lysis or reduction in growth [25]. Since autoclaving has 
been decided as the method for sterilization, the material must be able to withstand temperatures 
up to 121°C. This sterilizability is important as it will enable the system to be reused multiple 
times without the need to constantly manufacture another system after each operation. 
Reusability will be economically beneficial as well since there will be only a single-time cost in 
manufacturing the system.  
In the context of adherent bioreactor systems, one of the most fundamental aspects of 
design is the ability for cells to adhere to whatever scaffolding or surface is available within the 
system, and then properly proliferating to achieve maximum confluency. As such, the promotion 
of maximum confluency is extremely significant as this will enable the system to achieve the 
highest possible cell densities. This aspect in addition with volumetric efficiency is the main 
focus of optimization within the industry currently, where research is focused on generating the 
highest possible biological yield in the smallest volumes possible. The promotion of maximum 
confluency will thereby incorporate various aspects, such as providing a compatible surface 
capable of facilitating cellular attachment and proliferation, while also ensuring that the correct 
amount of oxygen and nutrients are supplied to the cells.   
 In terms of wants, there are several criteria which would be ideal for the team to 
incorporate into their design, although with the large amount of requirements and constraints this 
may not be as feasible. The first want is the ease of manufacturing the system. The ease will be 
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linked to the cost of the design, as both are related to the materials that are chosen as well as the 
complexity of the design. Manufacturing will also be related to the manufacturing method 
chosen by the team as well, as the team has a variety of options such as additive manufacturing 
or laser cutting. These are inherently connected to the final design of the product, and so as the 
team begins to prototype and devise the design, the manufacturing options will need to be 
assessed.  
Another want for the design is that it must be scalable. Many bioreactor processes require 
a scale up process from benchtop reactors to large-scale industrial bioreactors, and as such, 
although this is not necessary, it would be ideal to incorporate the potential of scalability within 
the design. This would mean a streamlined design that is capable of being scaled up or scaled 
down to account for a large range of seeding densities. This is considered more of a want than a 
need by the team because we believe that the current focus should be on creating a system first 
that is capable of demonstrating enhanced attachment and volumetric efficiency. Ideally, once 
this system is created, we will then be able to demonstrate scalability with the fabrication of 
different-sized models, as in the end scalability will be important for any potential industry 
translation.  
The final want for the design is the ease of the initial culturing process. It may be entirely 
possible that the culturing process is not modified at all with the current Cytodex systems, or it is 
modified but is still potentially as time-consuming, however another modification within the 
system is made which lowers the shear forces imparted on the cells. Ideally, this culturing 
process should be streamlined to contribute to the streamlining of the bioreactor operations, 
however this is considered more of a want than a need as the team acknowledges it may be 
possible to maintain the current seeding process if the final design is able to incorporate another 
modification that mitigates the detachment of cells and improves the attachment efficiency.  
 In order to determine the important aspects of our primary design objectives, we 
compared the design needs and wants to each other using a Pairwise Comparison chart, as shown 
in Table 6: Pairwise Chart Comparison. The chart gives a ranking to each factor on a scale of 0 
or 1 to determine which factor is more important than the other. A ranking of 1 means that the 
factor on the left of the chart is more important to the team than the factor on the top of the chart 
and a ranking of 0 means the top factor was more important. A ranking of 0.5 means that the two 
factors being compared are equally important. The “X” in the chart denotes where the factor is 
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being compared to itself, therefore resulting in no ranking [27]. Table 7 is the total score of each 
factor and that determines the weight of the factors in order of importance. The pairwise 
comparison chart determined that the novel bioreactor being non-disruptive to cells and being 
volumetrically efficient are the most important factors, while scalability and ease of 
manufacturing were the least important factors. These top-ranked needs for the bioreactor system 
are important because ultimately, the bioreactor will be functioning as an environment for cells 
and therefore should not inherently cause cell death or impart a negative effect on cell function, 
while functioning within the smallest possible volume for maximum functional and economic 
efficiency.  
 
Table 6. Pairwise Comparison Chart 
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Table 7. Total weight from pairwise chart 
Design objective  Weight 
Non-disruptive to cells 4.5 
Volumetric Efficiency 4.5 
Sterilizable 4 
Promotion of Maximum Confluency 3.5 
Ease of Culture 2 
Scalability 0.5 
Ease of Manufacturing 0.5 
 
4.3 Concept Designs 
4.3.1 Conceptual Design Modifications 
 The modifications to be considered for the initial conceptual designs for fabricating an 
improved adherent bioreactor system are shown below in Figure 3: Initial Concept Design 
Modifications. These design modifications are broken up and categorized by two distinct 
functional aspects of the bioreactor, cellular attachment and confluency within the system, as 
previously detailed in Section 3.2.3: Functional Blocks. These modifications were previously 
brainstormed in the broader context of improving bioreactor operations, as shown in the concept 
map in Section 4.1: Initial Concept Map, however here they will be further discussed and 
developed in the specific context of improving adherent bioreactor cultures. Analyzing the 
bioreactor by these two functional groups gives a wide range of aspects to analyze and dissect as 
it allows the team to understand each components’ role and their interaction with other 
components in the optimization of the bioreactor operation.  
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Figure 3. Initial Concept Design Modifications 
 
As shown, three initial conceptual modifications have been brainstormed. In order to 
address the issue of cell attachment, two proposed modifications have been proposed: the usage 
of a continuous flow system and modifications to the microcarriers. The utilization of a 
continuous flow system would enable the recycling of unattached cells so that they are 
continuously in contact with the microcarriers. In the current systems, which utilize the Cytodex 
beads, cells that are unattached are simply left to float and die in suspension since they are 
unable to make sufficient contact with any microcarrier. The idea of continuous flow would 
enable the unattached cells to continuously travel through the system so that they can attempt to 
make contact again with the microcarriers. Additionally, a continuous flow achieves the 
bioreactor need for nutrient and oxygen exposure to the cells, effectively replacing the stirred-
tank system which utilized an impeller for homogeneous distribution. This will also allow for 
greater modifications over the shear stresses imparted since the impeller system will now be 
replaced. The modification to the microcarriers would entail potential surface modifications, 
such as oxygen plasma treatment or gelatin coatings, which have previously been shown to help 
enhance cell adherence to surfaces. Furthermore, it is possible to completely change the material 
of the microcarrier itself, so that a different substrate can be utilized, such as glass or plastic. 
Ideally, changing the surface material would enable improved attachment.  
Additionally, in the context of improving confluency in the system, another proposed 
modification is the utilization of a packed bed system. This would entail packing the 
microcarriers so that they are in close contact with one another, and then media containing the 
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cells, oxygen, and nutrients would flow through this packed bed. Ideally, cells would make 
sufficient contact with a microcarrier and then attach. The most important aspect of this design is 
that due to the closeness of all the microcarriers, cellular bead-to-bead migration would be 
possible. According to the client, one issue with the current Cytodex system is that due to the 
constant mixing of the stirred reactor, none of the microcarriers necessarily make sufficient 
contact with one another. As a result, there are many beads which are empty and do not contain 
cells. With the potential of bead-to-bead migration in this design modification, microcarriers 
which initially did not contain any cells are capable of providing an extra surface onto which 
cells from other beads can grow and attach onto. This would help to increase viable cell densities 
by effectively increasing the potential surface area for cell attachment and growth.  
In the end, the team decided to utilize all three modifications to fabricate a closed-loop 
packed bed bioreactor system.  This system integrates a packed bed system containing modified 
microcarriers, in addition to a continuous pumping mechanism. This design is discussed in the 
next section, while the design is further broken down into each individual component and 
detailed in Section 6.1 Final Design Overview. The materials utilized for the full system can be 
found in Appendix B: Bill of Materials, while a comprehensive list of each component of the 
bioreactor is found in Appendix C: Bioreactor Components.  
The potential for scalability has been considered as well. If a streamlined design is 
created, this would allow for potential manufacturing at any scale required, thus allowing for 
potential translation into the biomanufacturing industry. The other design needs, such as being 
easily sterilizable and non-disruptive to the cells will be met to similar degrees across all 
concepts through the use of specific materials and sterilization procedures that will suit the 
overall design and intended function. 
4.3.2 Alternative Designs 
The team generated several alternative designs to improve adherent cell culture. The first 
design incorporated the continuous pumping mechanism with the combination of a scaffold to 
replace the usage of microcarriers. The second design also incorporated the continuous pumping 
mechanism, but utilized the microcarriers in a packed bed design. The third design involved 
maintaining the current impeller system in the stirred tank bioreactors, and instead focused on a 
method to connect microcarriers as they were being mixed to achieve bead to bead migration. 
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Stackable Scaffold Bioreactor 
This design consisted of a stackable scaffold which would be placed inside the bioreactor 
vessel. The stackability of the scaffold offers a great advantage by being inherently compatible 
with scalability, granting different scalability options as more or less scaffolding could be used 
depending on the desired size of the bioreactor. This is the reason why the utilization of a 
scaffold was considered as a potential replacement for the microcarrier design, as the process of 
scaling up or down in bioreactor sizes will be significantly streamlined. The impeller system 
which is typically found in stirred tank bioreactors is replaced with a pumping mechanism that 
would pump the culture media from the bottom of the bioreactor to the top, thereby passing 
media, nutrients, and oxygen through the scaffolds for the attached cells. This pumping 
mechanism is important as it also enables unattached cells to be recycled within the system with 
the potential for them to attach onto the scaffold as they continuously pass through the 
bioreactor. This design can be seen below in Figure 4: 
 
 
Figure 4. Scaffold Bioreactor Design 
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Packed Bed Bioreactor 
 This design focuses on addressing cellular adherence in addition to volumetric efficiency 
with the utilization of a packed bed of microcarriers. The typical impeller system in the current 
Cytodex system is replaced with a continuous pumping mechanism, where the media 
continuously travels through this packed bed of microcarriers, so that cells that are unable to 
attach are looped back into the beginning of the system in an attempt to seed them onto the 
beads. The replacement of the impeller system helps to reduce shear forces since the intermittent 
stirring method is no longer required. This continuous pumping mechanism also provides a 
method for nutrients and oxygen to be constantly delivered to cells seeded within the packed bed 
of microcarriers. The packed bed itself enables an increase in available surface area for cellular 
adherence since many microcarriers can be packed together within a smaller volume in 
comparison to the current Cytodex system, where the microcarriers are homogeneously mixed 
throughout the volume. In addition, cellular bead to bead migration is possible due to the dense 
packing of the microcarriers, further enabling confluency and cellular proliferation to achieve 
higher amounts of cell densities. This design can be seen below.  
 
Figure 5. Packed Bed Design 
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Interlocking Microcarriers 
 This design involved maintaining the current stirred tank bioreactor system that is utilized 
in the Cytodex system, while focusing on increasing the potential surface area for cellular 
adherence and proliferation through interlocking microcarriers. One main issue with the current 
Cytodex system is that there is a lack of bead to bead cellular migration, and as such 
microcarriers which were not seeded with cells initially will likely never be able to contain any 
cells since the attached cells are confined only to the bead they initially attached to. This severely 
limits the available surface area for cells. As such, this design incorporates the utilization of 
polarized glass beads, half of which are positively charged and the other half which are 
negatively charged. While the initial intermittent seeding method will still be utilized, as the 
microcarriers are mixed within the bioreactor, the polarized charges will enable the positively 
charged beads to become attracted to the negatively charged beads. This will increase the 
available surface area for the initial seeding phase, while also enabling cells to migrate between 
microcarriers, which will also increase the available surface area for cellular growth and 
confluency.  
4.3.3 Final Design Selection  
 With mentioning the alternative designs the team had contemplated in addition to the 
final design, it is important to detail the process we utilized in the selection of our final design. 
The Pugh Selection method was utilized in conjunction with the total weights generated in the 
Pairwise Comparison in Section 4.1 Needs Analysis. The Pugh Selection method compares the 
scaffold bioreactor design, the packed bed bioreactor design, and the interlocking microcarriers 
design with the current baseline Cytodex system in order to generate scores that determine which 
design is more capable of fulfilling the design objectives. A rating of 1 indicates that the 
alternative design improves on a specific aspect of the baseline Cytodex system, while a rating of 
-1 indicates that the alternative design is actually worse in that aspect than the baseline system. A 
rating of 0 indicates that the alternative design and the baseline design are equivalent to each 
other for that specific aspect. This Pugh Selection method is detailed below in Table 8. 
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Table 8. Pugh Selection Method  
 
  
As shown, the packed bed bioreactor demonstrated the most functional benefits as it had 
a higher score in comparison to the scaffold bioreactor and interlocking microcarriers design. 
The most significant difference between the designs was their capabilities of volumetric 
efficiency. The scaffold bioreactor is volumetrically inefficient, due to the large amounts of dead 
space in between each portion of the scaffold. Although recycling of unattached cells is achieved 
in this design with the utilization of a pumping mechanism, the surface area to volume ratio 
would be very low in comparison to the packed bed design. The interlocking microcarriers 
design promotes the maximum possible confluency within the system, however the utilization of 
microcarriers in a stirred tank reactor is still volumetrically inefficient due to the large amounts 
of volume required. Additionally, this system is still disruptive to cells as the intermittent stirring 
system would be required with the impellers in place. In contrast, the packed bed design enables 
high amounts of packing, which would promote cellular migration between beads and increase 
the total surface area available for cells to spread and grow. This bead-to-bead migration is the 
most important aspect of the packed bed reactor, as it is volumetrically efficient and allows for 
cells to spread onto microcarriers which may not have previously contained any. As a result, the 
team decided to utilize the packed bed design as our final novel design.  
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4.3.4 Feasibility Studies 
 As the design undergoes several iterations up until the final design, the team conducted 
several feasibility studies to determine the practicality and functionality of the design and where 
potential improvements can be made. A simple preliminary cell attachment was performed in 
order to compare the usage of Cytodex beads with other potential substrates, such as glass beads, 
in order to determine if the final design should utilize the current microcarrier technology on the 
market or attempt to utilize another material with the hopes of improving cell attachment and 
bead-to-bead cellular growth. This was done by seeding cells into wells which contain a small 
layer of the material of interest, and waiting for an extended period of time before staining and 
utilizing a fluorescent microscope to observe cell behavior. Additionally, calculations were 
performed to ensure the feasibility behind the bioreactor system in terms of oxygenation and 
shear stresses. It should be verified that the bioreactor will not generate forces capable of 
detaching cells during the culturing process, and that enough oxygen is provided for the culture. 
These can eventually be fully verified once the bioreactor system is translated into adherent cell 
culture with the examination of the cells and their health within the packed bed. The results of 
these studies are detailed in Chapter 5: Final Design Verification and discussed in Chapter 7: 
Discussion. 
 A final test will be conducted comparing the current microcarrier technologies of 
utilizing Cytodex beads in a bioreactor with the current intermittent stirring protocol in 
comparison to the continuous flow bioreactor containing a packed bed of carriers. This 
experiment will have to be controlled, wherein the same cell density is seeded into both systems, 
and waiting for a period of time before the cultures are stopped at the same time. Afterwards, 
both systems will be examined utilizing fluorescent staining to compare cell growth, and both 
systems will be compared in terms of final cell count and viability. The purpose of this is to 
determine whether or not the new, experimental design is capable of increasing attachment 
efficiency as well as final cell yield.  In the end, the experimental bioreactor should display equal 
or improved results compared to the control method of utilizing Cytodex microcarriers with 
intermittent stirring. The expected results are detailed in Chapter 5: Final Design Verification 
and discussed in Chapter 7: Discussion.  
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4.4 Relevant Design Calculations and Parameters 
As stated previously, the feasibility of the bioreactor relies on how it affects and interacts 
with cells. In order to test this feasibility, we plan to examine multiple parameters pertaining to 
cells that are in our bioreactor as well as a standard control bioreactor to compare the two. This 
will allow us to determine the effectiveness of our bioreactor in terms of cell biocompatibility 
and cell health. Human dermal fibroblast cells will be utilized with our bioreactor, and will be 
maintained in accordance to WPI Professor Ambady’s subculturing protocol, which can be found 
in Appendix D: Protocols.  
The first parameter that must be examined is determining the number of live and dead 
cells from the bioreactors. In order to do this, we used a cell counting hemocytometer. These are 
able to give us the amount of total cells, but in order to determine which cells are dead or alive, 
we must stain the cells with Trypan Blue, where those that are alive will not be stained and those 
that are dead will be stained blue. Once the amount of live and dead cells was determined, we 
could calculate different parameters based on these numbers. One parameter we will be 
examining is doubling time, which is the amount of time it takes for the cells in the bioreactor to 
double in population size. The doubling time is determined by the following equation, 
 
DT = T
ln(2)
ln(Xe/Xb)
                             (1) 
 
where DT is the calculated doubling time, T is the incubation time or the period of time chosen 
for the cells, Xb is the number of cells at the beginning of the incubation time, and Xe is the 
amount of cells at the end of the time indicated [28]. Another parameter needs to be examined is 
the cell viability, which details the amount of healthy cells in comparison to the total number of 
cells both living and dead. Thus, cell viability is simply the amount of live cells counted divided 
by the total amount of cells. This will result in a viability percentage [29]. 
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4.5 Physical and Mathematical Models 
4.5.1 Physical Modeling 
 When designing our bioreactor, we utilized the SolidWorks program in order to create a 
3D model of our final product. SolidWorks also allowed us to see the physical properties of the 
model like center of mass, weight, and strength based on the material used. SolidWorks models 
of our bioreactor and each of its components can be found in Section 6.1 Final Design Overview. 
4.5.2 Mathematical Models 
Since we are creating a novel bioreactor, we understand that we will need to characterize 
the fluid flow within the packed bed design and the shear stresses generated. Additionally, the 
amount of oxygen consumed and delivered will need to be characterized to ensure the 
oxygenation requirements of the cells are met. These mathematical models are listed below. 
 
Ergun Equation: 
Since the final design will incorporate a packed bed bioreactor design, the characterization of the 
fluid flow is significant. The Ergun equation enables fluid characterization of packed bed designs 
by relating the pressure drop along the length of the packed bed given a constant flow rate as 
fluid passes through the packed bed [30]. This constant velocity is related to the constant 
volumetric flow rate imparted by the provided peristaltic pump. The formula for the Ergun 
equation is given below, 
 
ΔP = (
150μ(1−ε)2u0
ε3dp
2 +
1.75(1−ε)ρu0
2
ε3dp
)  ∗ L             (2) 
 
where ΔP is the calculated pressure drop, L is the height/length of the packed bed, µ is the fluid 
viscosity, ε is the void space within the packed bed, u0 is the fluid superficial velocity, dp is the 
diameter of the particles in the packed bed, and ⍴ is the density of the fluid. 
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Shear Stress Calculation 
The associated pressure drops across the length of the packed bed can be related to a 
corresponding shear stress which calculates the amount of shear stress each bead within the 
packed bed would experience [31]. This is given below, 
 
τ =
ΔP∗A
SA
                  (3) 
 
where τ is the calculated shear stress, ΔP is the calculated pressure drop from Equation (2), A is 
the cross sectional area of the fluid flow, and SA is the surface area of the packed bed. 
 
Oxygenation 
A significant parameter that must be considered is whether or not the bioreactor will properly 
supply the required amount of oxygen to the cells within the bioreactor. As such, the following 
equation details how to calculate the amount of oxygen consumed every second by the packed 
bed of microcarriers, 
 
O2,C = Ccells ∗ O2,cell                           (4) 
 
where O2,C is the maximum amount of oxygen consumed, Ccells is the maximum amount of cells 
in the packed bed, and O2,cell is the theoretical oxygen consumption rate per cell. The following 
equation details how to calculate the amount of oxygen supplied by the pump every second, 
 
O2,D = DO2 ∗ Q                            (5) 
 
where O2,D is the calculated rate of oxygen delivery, DO2 is the theoretical dissolved oxygen in 
media, and Q is the volumetric flow rate of the pump into the bioreactor vessel. 
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Chapter 5: Final Design Verification 
Several preliminary experiments were performed to optimize the final design and verify its 
design before being translated into adherent cell culture. The first experiment involved 
comparing the volumetric efficiencies of the novel bioreactor and the current Cytodex system by 
determining the maximum possible cells per unit volume in each system. The next experiment 
was based on determining an optimal microcarrier material for the new design, comparing the 
current Cytodex 1 microcarriers with larger, surface modified glass beads. The third test 
involved theoretical calculations aimed at examining the pressure drop across the packed bed and 
associated shear stresses, and whether or not enough oxygen would theoretically be delivered to 
cells in the packed bed. The last experiment was a fluid test in order to verify the design and 
ensure that there were not any leaks, and that fluid properly flowed through the bioreactor 
system. 
5.1 Volumetric Efficiency Comparison  
 When comparing our novel bioreactor to the current Cytodex system, it is important to 
understand how utilizing a packed bed of microcarriers is more volumetrically efficient than 
simply having microcarriers in suspension. This volumetric efficiency can be defined as the total 
number of cells supported per unit volume of the reactor. The calculations can be found in 
Appendix E: Relevant Design Calculations.  
 First, a simple confluency experiment was run where dermal fibroblast cells were 
allowed to reach 100% confluency in a Corning T-25 flask. This flask was used since it is known 
that its surface area is 25 cm2. Once 100% confluency was reached, the cells were subcultured 
and counted to determine the total number of cells. It was found that a surface area of 25 cm2 
contained 1.14 x 106 cells, indicating that the number of cells per unit surface area is 4.55 x 10-4 
cells / µm2. Afterwards, the surface area to volume ratio for the Cytodex system and our novel 
system was calculated. This ratio could be calculated for the Cytodex system as the GE Cytodex 
1 manual indicated the amount of surface area per gram of Cytodex, which was 4,400 cm2 per 
gram [32]. The ratio for the novel system was calculated knowing the volume of the bioreactor 
and the maximum total number of beads possible. Once these ratios were calculated, they were 
multiplied by the previously calculated number of cells per unit surface area, thereby giving the 
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total number of cells supported per volume of the bioreactor. This is summarized in Table 9 
below.  
 
Table 9. Volumetric Efficiency Comparison 
Bioreactor System Surface Area per Unit 
Volume (um2 / L x 1012) 
Cells per mL (x 105) 
Cytodex System 1.32 6.01 
Novel System 8.66 39.3 
 
Once the volumetric efficiencies are calculated, they can simply be divided by one 
another in order to determine the increase in efficiency. As such, the novel system is 6.5-times 
more volumetrically efficient, as it can support 6.5-times the number of cells per unit volume 
than the Cytodex system.  
5.2 Microcarrier Optimization 
An initial experiment was run in order to observe how the cells adhered to the 
microcarriers including the Cytodex I microcarriers from GE Healthcare and the glass beads with 
various surface modifications. The glass beads utilized were Megalux Uncoated Glass Beads 
30/40 Mesh, manufactured by Swarco with a diameter range of 425 - 600 µm. The surface 
modifications that were done to the glass beads included separate gelatin coating treatments and 
oxygen plasma treatments. The protocol for this experiment can be found in Appendix D: 
Protocols under the Microcarrier Attachment Experiment Protocol. After the beads were each 
seeded in triplicate in a 12 well plate and incubated for three days they were stained in Hoechst 
and imaged. The control microcarriers, Cytodex I, are shown in Figure 6.  
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Figure 6. Cells on Cytodex 1 Microcarriers 
 
The glass beads that were unmodified are shown in Figure 7. As can be seen there are some cells 
on the surface of the beads, but a majority lie in the spaces between beads. 
 
 
Figure 7. Cells on Unmodified Glass Beads 
 
Cytodex 
microcarrier 
Glass 
microcarrier 
Cells 
Cells 
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The glass beads that were modified using a gelatin coating show a dispersion of cells over the 
surface. There is some more congregation of cells in certain areas compared to others. The 
images of these beads can be seen in Figure 8.  
 
 
Figure 8. Cells on Gelatin Coated Glass Beads 
 
The glass beads that were treated with oxygen plasma are shown in Figure 9. There are cells that 
reside on the outer surfaces of the beads throughout all sections of the bead, as well as observed 
migration and growth between the beads.   
 
 
Figure 9. Cells on Plasma Treated Glass Beads 
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5.3 Ergun Equation and Oxygenation Calculations 
 Before running the bioreactor with adherent cells, it was determined whether or not the 
provided pump is capable of handling the pressure drop across the packed bed, as well as 
whether or not enough oxygen will be provided to the cells. These are done utilizing Equations 
(2), (3), (4), and (5). The physical calculations and associated assumptions can be seen in 
Appendix E: Relevant Design Calculations. Equations 3 and 4 were solved as a function of the 
flow rate, calculating what the theoretical pressure drop and associated shear stress on each 
microcarrier would be for a variety of flow rates. These calculations were performed under the 
assumption of monodispersity, where every microcarrier was the same diameter, while also 
assuming the densest possible packing (74%) and that media properties are similar to that of 
water [33]. These results are shown in Table 10 below: 
 
Table 10. Range of Pressure Drops and Shear Stresses 
Flow Rate 
(mL/min) 
Pressure Drop 
(Pa) 
Shear Stress 
(dynes/cm2) 
30 870 2.63 
35 1020 3.07 
40 1170 3.52 
45 1320 3.96 
50 1460 4.41 
55 1610 4.85 
60 1760 5.30 
65 1910 5.75 
70 2060 6.20 
75 2210 6.66 
 
 As shown, these pressure drops are very small, almost negligible, especially in 
comparison to the back pressure of 172 kPa that the pump is capable of supporting. It is 
calculated that once the flow rate of the system reaches approximately 75 mL/min, the upper 
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limit of 6.5 dynes/cm2 is reached, which is below the limit detailed in Section 3.2.5: Design 
Requirements and Specifications. Oxygenation rates were also calculated as a function of flow 
rate, as shown in Table 11 below:  
 
Table 11. Oxygen Delivery Rates 
Flow Rate 
(mL/min) 
Total O2 
Delivered 
(mg/sec x 10-4) 
5 3.33 
10 6.67 
15 10.0 
20 13.3 
25 16.7 
30 20.0 
35 23.3 
40 26.7 
45 30.0 
50 33.3 
 
 These calculations were performed under the assumption that every microcarrier within 
the packed bed would be 100% confluent with cells. The calculations and assumptions for 
determining the number of beads and cells for a specific packed bed length can be found in 
Appendix E: Relevant Design Calculations. For example, it was assumed that the dissolved 
oxygen concentration in the media is similar to that within water. Additionally, these delivery 
consumptions were calculated taking into account a safety factor for the amount of dissolved 
oxygen in water. It was determined that the maximum dissolved oxygen concentration in water 
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at 37 ℃ is 6.81 mg/L, and so a safety factor was used so that the concentration used in the 
calculations was 4.00 mg/L [34]. It was also assumed that the oxygen consumption rates of each 
cell was 1.19 x 10-7 mol O2
 per second [35] These calculated ranges of oxygen consumption can 
be compared to the theoretical total oxygen consumed by the system, which is 1.07 x 10-4 
mg/sec. The calculations for determining the theoretical total oxygen consumption can be found 
in Appendix E: Relevant Design Calculations. If the total oxygen consumption rate is lower than 
the total delivered oxygen rate, then this would indicate that the bioreactor system is capable of 
supporting the packed bed in terms of supplying enough oxygen for the cells.  
5.4 Bioreactor Fluid Test 
 After the novel bioreactor was initially fabricated, a bioreactor fluid test was performed 
to validate that continuous flow was achieved within the system, while ensuring that no visible 
external leaks were occurring. The protocol for this experiment can be found in Appendix D: 
Protocols under the Fluid Validation Test Protocol. After setting up the full bioreactor system, 
water was run throughout the system, as shown in Figure 10 below: 
 
 
Figure 10. Initial Fluid Test with Water 
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As shown, the bioreactor was able to successfully be primed so that water was 
continuously flowing through it. Upon inspection at certain interfaces in the design, no visible 
leaks were found. Afterwards, green dye was injected in order to better visualize the liquid flow, 
as shown in Figure 11 below: 
 
 
Figure 11. Initial Fluid Test with Green Dye 
 
The green dye helps to indicate the presence of fluid within the system, showing that 
fluid is properly flowing into the bioreactor through the inlet hose nipple and out of the 
bioreactor throughout the outlet hose nipple. It should also be noted the presence of green dye 
within the glass tubing surrounding the middle insert. Finally, after draining the bioreactor from 
the water, the bioreactor was taken apart and the middle insert was upon up, showing the 
presence of beads as shown below: 
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Figure 12. Middle Insert with Dyed Glass Beads 
 
As shown, the glass beads are still present within the middle insert, indicating that they 
were not forcibly pushed out of the middle insert by the continuous flow. This also validates that 
the metal mesh screen was capable of allowing fluid through, while being small enough to 
contain the beads. Additionally, the green tint on the glass beads indicates that liquid properly 
flowed through the middle insert, since the green dye was able to pass through the beads and dye 
them green. In the end, this experiment validates that continuous flow was achieved in the 
bioreactor system and that fluid is capable of passing through the middle insert properly without 
disrupting the beads.  
5.5 Novel Bioreactor Comparison Study 
After running these initial preliminary tests, the novel bioreactor will be compared to the 
current adherent system with Cytodex 1 microcarriers in terms of cellular viability and density. 
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Both systems will be seeded at the same initial densities, and the nutrient profiles would be 
generated, finally resulting at the end of the study a cell density comparison. Unfortunately, due 
to circumstances surrounding COVID-19, the team was unable to conduct this comparison study. 
As a result, the next sections will detail the nutrient tests that would have occurred during the 
experiment, as well as the final density test that would have been conducted at the end of the 
experiment to compare cell densities between the two systems.  
5.5.1 Nutrient Tests 
 Throughout the course of the experiment, nutrient and metabolite data would have been 
generated in both bioreactor systems for comparison, testing for specific nutrients including 
Glucose, Glutamax, Glutamate, Lactate, Ammonia, and Lactate Dehydrogenase (LDH) levels in 
the media. Conducting a comparison between the two would help to demonstrate whether or not 
the bioreactors are comparable in terms of nutrient depletion, especially since Cytodex adherent 
cultures have already been characterized in these types of studies. The protocol for conducting 
these nutrient tests can be found in Appendix D under the Nutrient Testing Protocol. Nutrient 
testing would have been conducted every day for the entirety of the comparison study in order to 
create nutrient curves. A sample nutrient curve is shown below [36]: 
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Figure 13. Sample nutrient curve 
 
 As shown, it would be expected for glucose, glutamax, and glutamate levels to decrease 
since these are nutrients for cell consumption, whereas lactate and ammonia levels would 
increase since they are cellular byproducts. LDH is a specific cytosolic enzyme which is released 
from the cell into the media upon cell death, and as such its levels can be utilized as an indicator 
for cellular viability by running LDH assays in addition to the nutrient tests. It would be 
expected that at the very least, both the control and novel bioreactor would generate similar 
trends in their respective nutrient curves. However, differences between in the novel bioreactor 
curves would have been expected, as this would be indicative of differences in the cell culture 
and amounts of cells.  
 A control experiment would have initially been run as well which examines nutrient 
growth curves for the human dermal fibroblast cells when in normal adherent cell culture in a T-
flask. This generates a baseline nutrient data curve for which the bioreactor curves could be 
compared to as well. Additionally, utilizing this baseline nutrient curve would help to correspond 
nutrient depletion with confluency and cell growth. This is due to the fact that with a normal T-
flask, confluency can be examined under a normal phase contrast microscope, and so doublings 
53 
 
in confluency, indicative of doublings in the cell population, can be correlated to specific trends 
in the nutrient curve. For example, a specific percentage decrease in glucose levels can be 
correlated to a doubling of the cell population. As such, this correlation can then be applied to 
the bioreactor nutrient curves to extrapolate data in terms of cell doubling.  
5.5.2 Final Density Tests  
At the end of the system run of both bioreactors, the final densities of cells on the two 
types of microcarrier technology would have been calculated and compared. The two systems 
would have been seeded with the same amount of cells in order to accurately compare the final 
cell densities at the end of two weeks. The final cell densities would have been compared for 
both cell attachment and cell growth. The protocol for conducting the final cell density tests can 
be found in Appendix D under the Final Cell Density Protocol. The differences in cell densities 
would have been used to highlight the impact of the novel bioreactor on adherent cell culture.  
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Chapter 6: Final Design and Validation 
The final bioreactor system is composed of many parts, all of which are required to meet the 
safety and industry standards. Additionally, there are other considerations that need to be 
considered such as the economic impact of the device, the ethics of the device, and the 
manufacturability of the device. 
6.1 Final Design Overview 
The final design can be broken into four major sections: the main bioreactor vessel itself, 
the pump, the media bottle, and the tubings which act as conduits to connect everything together. 
A bill of materials containing all the specific materials utilized by the team can be found in 
Appendix B: Bill of Materials, while a simplified checklist of each section and their components 
can be found in Appendix C: Bioreactor Components, which will be useful when assembling the 
full bioreactor system. 
 
Main Bioreactor Vessel 
The main bioreactor vessel can be broken down into four components, the two end 
pieces, the middle glass tube, and the middle insert in the glass tube. Additionally, there is a base 
mount onto which the main bioreactor vessel can be screwed onto. The packed bed of glass 
microcarriers are held in place inside the middle insert. The full vessel setup is shown below 
with labels of each component: 
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Figure 14. Solidworks models of main bioreactor vessel 
 
 
Figure 15. Solidworks drawing of main bioreactor vessel 
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Figure 16. Solidworks drawing of bioreactor cross section 
 
 The first component to mention is the base mount. A full picture of the mount and its 
dimensions are shown below: 
  
Figure 17. Solidworks models of base 
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Figure 18. Solidworks drawing of base 
 
This component is made of 316 Stainless Steel, allowing it to be autoclavable, and 
contains screw holes which line up with screw holes on each of the end pieces. This allows for 
the bioreactor vessel to be screwed onto the mount, suspending it so that it can be run vertically. 
This is important as this will allow the bioreactor vessel to be easily stored within an incubator, 
as the bioreactor can be mounted on the base, and then simply placed on a shelf.  
 The next components are the two end pieces. Picture of the front and back are shown 
below: 
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Figure 19. Solidworks models of end piece 
 
 
Figure 20. Solidworks drawings of end piece 
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Both of these pieces are made from 316 Stainless Steel as well, allowing them to be 
autoclavable. Both of these end pieces are attached to the top and bottom of the bioreactor vessel, 
serving as the inlet and outlet for the system. To accomplish this, both end pieces contain a hose 
nipple, allowing tubing to be connected to each one, and the end pieces themselves are hollow. 
Through this, cell culture media and any unattached cells will be flown into and out of the 
bioreactor in a continuous loop. The backs of each end piece also contain two screw holes, 
thereby allowing the bioreactor to be mounted onto the base mount. The inside of the end pieces 
is shown below: 
 
Figure 21. Solidworks model of end piece cross-section 
 
 As shown, the hollowed opening from the hose nipple connector tapers out until the final 
inner diameter is reached. One important aspect of the end pieces is the placement of O-rings 
within each of them. A groove exists within the end piece, onto which the O-ring can be placed 
onto. This O-ring interacts with the glass tube, and since it is the same diameter as the glass tube, 
will create a water-tight seal, generating a leak-free interface so fluid will move smoothly 
between the glass tubes and the end pieces.  
 The next component is the borosilicate glass tube. This glass tube connects to the end 
pieces and acts as a housing unit to contain the middle insert. A picture of the glass tube is shown 
below: 
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Figure 22. Solidworks model of glass tube 
 
 
Figure 23. Solidworks drawing of glass tube 
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 The glass tube is inserted into each of the end pieces through a twisting, pulling motion. 
The outer diameter of the glass tube is the same as the inner diameter for each of the end pieces, 
and so the interfaces created with the O-rings in each of the end pieces creates a water-tight seal. 
This glass tube functions as a container for the middle insert. Additionally, borosilicate glass is 
capable of withstanding autoclaving temperatures, thereby making it easily autoclavable with the 
rest of the system.  
 The final component for the vessel is the middle insert. The middle insert is responsible 
for holding the packed bed of microcarriers and ensuring that it is stable. Pictures of the middle 
insert and the screw caps as shown below: 
 
Figure 24. Solidworks model for middle insert 
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Figure 25. Solidworks model for middle insert end caps 
 
 
Figure 26. Solidworks drawing for middle insert 
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Figure 27. Solidworks drawing for middle insert end caps 
 
 
Figure 28. Solidworks drawing for steel mesh 
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 As shown, the middle insert consists of a main vessel with two screw caps on each end. 
Both the main vessel and the screw caps contain threads, allowing the caps to easily be screwed 
onto the main vessel. Each of the screw caps contains a 316 Stainless Steel mesh screen, as well 
as an O-ring. The O-ring helps to create a water-tight interface with the main middle insert 
vessel, while the mesh screen is utilized to allow fluid flow while being small enough to hold the 
glass beads in place, thereby creating a packed bed of microcarriers capable of supporting bead 
to bead migration.  
 
Peristaltic Pump 
The peristaltic pump is an essential component to the bioreactor system, as it interfaces 
with the tubings in order to create continuous flow within the system. The utilization of the pump 
is shown below: 
 
 
Figure 29. Bioreactor Interaction with Pump 
 
The pump that it utilized is a Manostat E-Series Peristaltic Pump provided to the team by 
Professor Page. This pump runs at a volumetric flow rate of 56.8 mL/min, while being capable of 
supporting back pressures up to 172 kPa (or 25 psi) when dealing with continuous flows. As 
shown, the top port of the pump interacts with tubing connected to the media bottle. This is the 
65 
 
inlet port of the pump, while the outlet port of the pump interacts with tubing connected to the 
inlet hose nipple of the bioreactor vessel. As such, fluid will flow from the media bottle through 
the pump and into the bioreactor, eventually flowing out of the bioreactor through the outlet hose 
nipple and back into the media bottle. In the depiction above, the container acts as the media 
bottle of the system, which is described further in detail below. This establishes the continuous 
flow which would allow for media to be run through the packed bed of microcarriers containing 
cells, while any unattached cells will simply continue flowing through the system to provide 
more opportunities for these cells to interact with the packed bed and potentially adhere to a 
microcarrier.  
 
Media Bottle 
 A media bottle is used in order to create a basin for cell media to continuously be pumped 
into and out of the bioreactor system. Unfortunately, the media bottle was unable to be set up due 
to circumstances with COVID-19. However, a 1L media bottle would have been utilized 
containing approximately 400 mL of cell media, which would have been enough volume to 
completely fill the bioreactor system while also having enough extra in the media bottle. The 
media bottle cap would have contained ports, onto which tubings can be connected to. A 
representative image is shown below [37]: 
 
 
Figure 30. Media Bottle Setup 
 
66 
 
 The representative image highlights a media bottle with two ports. For the purposes of 
the novel bioreactor system, three ports would have been utilized instead, with two of those ports 
containing dip tubes inside of the media bottle. These two ports would act as the “inlet” and 
“outlet” ports for the media bottle. The “inlet” port would connect to tubing that connects to the 
inlet port for the peristaltic pump, and through this port media and any cells in the media would 
be supplied into the inlet of the bioreactor. The “outlet” port of the media bottle would be 
connected with tubing connected to the outlet hose nipple of the bioreactor vessel. Therefore, 
media and any unattached cells will flow through the bioreactor outlet and back into the media 
bottle. Additionally, a third port will be utilized which contains a 0.22 µm filter. This filter will 
be utilized to help filter the air inside the incubator so that oxygen is capable of traveling into the 
media bottle and oxygenating the media, thereby providing an oxygen source capable of 
supporting the oxygen consumption of the cells in the bioreactor.  
 
Tubings 
The tubings utilized are simply polyurethane tubings found in the GH 207 lab with an 
inner diameter of 5 mm. It should be noted that generally polyurethane is not an autoclavable 
material, and as such for translation into cell culture these tubings should be replaced with 
silicone tubings. Silicone tubings are typically found in biomanufacturing processes due to their 
ability to be autoclaved with the full system.  
 
The Packed Bed Design 
 As mentioned previously, the packed bed of microcarriers is contained within the middle 
insert. A simple depiction of this packed bed is visualized in Section 4.3.2 Alternative Designs in 
Figure 5. The packed bed utilizes glass microcarriers, specifically Megalux Uncoated Glass 
Beads 40/30 Mesh, with a diameter range of 425 - 600 µm. This packed bed is the core of the 
bioreactor system, as the dense packing helps to provide a volumetrically efficient system that 
maximizes surface area within a small bioreactor volume. The packed bed enables cellular 
migration in between each microcarrier, enabling a mechanism which allows for cells to migrate 
onto microcarriers which may not have initially contained any cells. As such, microcarriers will 
be maximally utilized within adherent cell culture.  
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The Full System 
 Each of these components are then combined to create the full closed-loop bioreactor 
system, as depicted below in Figure 31. 
 
 
Figure 31. Full Bioreactor System 
 
 Through this closed-loop system, culture media containing nutrients, dissolved oxygen, 
and any unattached cells will constantly flow through the bioreactor vessel, promoting cellular 
growth and proliferation in the system while also enabling the recycling of unattached cells. This 
recycling is an important aspect as it will aim to maximize cellular adherence within the packed 
bed. The protocol to set up and break down the bioreactor system can be found in Appendix D: 
Protocols.  
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6.2 Mechanical System for Improved Insert Access 
 
 
Figure 32. Insert removal process 
 
 Upon completion of the final reactor design, it was determined that the middle insert was 
too difficult to remove without disassembling the entire reactor, which raised both ease of access 
and contamination concerns. In order to address these concerns, it was determined that a 
mechanical system should be developed with the express goal of increasing ease of access to the 
insert as well as reducing human contact with the cells in the middle insert. In order to 
accomplish these goals, the main bioreactor vessel was outfitted with a series of modifications to 
its middle insert as well as the inclusion of a hinge attachment being incorporated into the bottom 
attachment point between the reactor shell and the base. 
 
Constraints 
 Before designing the mechanical system, a few constraints needed to be recognized in 
order to ensure the success of the final design. Foremost, the entire mechanism was required to 
fit within the space of the reactor chamber. The final design of the main bioreactor vessel 
included only twenty-eight millimeters of clearance between the middle insert and the top of the 
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chamber. Therefore, the mechanism would need to be compact enough to be contained within 
this space while still meeting its goals. Additionally, the surface area provided within the reactor 
upon which to build supports for the mechanism was limited to that which was provided by the 
surface of the insert end caps. This was essential to maintain the fluid flow integrity of the 
system, and avoid disrupting or altering the flow of media through the reactor chamber. 
Furthermore, the mechanism was required to bear all mechanical stresses imparted upon it during 
both the removal process, as well as while the reactor is operating. Finally, the mechanism 
needed to be sterilizable through the same methods used to sterilize the middle insert itself, and 
would therefore be machined out of 316L stainless steel as a part of the existing designs. 
 
Design Solution 
 
In order to meet the design objectives, it was decided that the middle insert would be 
modified with a spring loaded mechanism and carrying handle that would allow for the middle 
insert to compress within the space of the reactor chamber and then extend to provide easy 
access to a technician trying to remove it.  
 
 
Figure 33. Solidworks model of modified, spring loaded middle insert 
 
In addition to the modified insert, it was decided that the reactor shell be given the ability 
to rotate forward and away from the reacto base in order to provide clearance to remove the 
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insert while not having to detach the upper end piece of the reactor. This would allow the user to 
slide the upper end piece up the reactor after loosening the bolts that attached it to the slots in the 
base, and then rotate the vessel forward in order to extract the insert. In order to accomplish this, 
a hinge was designed and modeled to replace the bottom base to end piece attachment point. 
 
  
Figure 34. Solidworks model of hinge component 
 
Mechanical Stress Requirements 
 Before designing the modifications that were to be made to the middle insert, an analysis 
of the expected maximum stresses that each component would need to endure was performed. 
This would ensure that each component would be given enough load bearing surface area in 
order to support the forces imparted upon it by the springs in compression as well as the removal 
process.  
 The first step undertaken to perform this analysis was to choose a spring that would be 
capable of supporting the weight of the insert, but not incorporate any excessive pressure that 
might damage the insert or the reactor chamber. For this reason, it was decided that a set of four 
small springs would be used. The springs used were determined to maintain a resting equilibrium 
length of twenty millimeters and have the ability to lift the insert ten millimeters above the glass 
tube upon removal of the top end piece. The weight of the backed middle insert was measured 
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and determined to be 6.67 Newtons, or about one pound. With these metrics determined, the 
following spring force equation was applied to determine the spring constant (k). 
 
F/4 = kx                                 (6) 
 
 By substituting F and x for the weight of the insert and 0.01 meters respectively and 
solving for the spring constant, it was determined that each spring would hold a spring constant 
of 164 N/m. This value was then returned to the same equation evaluated at full compression of 
the spring (x = 0.02) in order to determine the force each spring would exert on the system when 
under full compression within the bioreactor. This force was multiplied by the number of springs 
(four) in order to acquire the total compressive force exerted by the springs on each component 
of the modified insert. The resulting force was calculated to be 13.37 Newtons. With the 
compressive force determined, the minimum surface area of the load bearing components could 
be determined.  
Both ends of the modified insert would need to be capable of bearing the calculated 
compressive load once the mechanism entered compression in the sealed bioreactor, multiplied 
by a safety factor of 50 to account for any unforeseen additional compressive forces that may be 
applied. In order to calculate the minimum surface area required to withstand the compressive 
forces, the following equation was applied, 
 
Asc = 50Fc/Yc                 (7) 
 
where Asc is the minimum surface area, Fc is the compressive force exerted by the springs, and 
Yc is the compressive yield strength of 316L stainless steel (170MPa) [38]. As a result, the 
minimum surface area required to withstand the compressive forces exerted by the springs was 
calculated to be 3.97x10-7 m2. 
In addition to compressive stresses, any handle designed to lift the middle insert out of 
the reactor chamber would need to support a tensile force equal to the weight of the weight of the 
insert multiplied by a safety factor of 50 which was determined to cover any unforeseen 
additional forces that may be imparted when lifting the insert. In order to calculate the minimum 
surface area, the following equation was applied: 
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Ast  =  50Fw/Ys                                 (8) 
 
Where Ast is the minimum surface area, Fs is the force imparted by the weight of the insert, and 
Ys is the tensile yield strength of 316L stainless steel (205MPa) [39]. As a result, the minimum 
surface area required to bear the tensile stresses at a safety factor of 50 was determined to be 
1.3x10-8 m2.  
 
Design Solution 
Once the mechanical stress requirements were determined, the physical modifications 
could be designed. Keeping the constraints and minimum surface area requirements in mind, the 
handle and spring loaded modifications to the middle insert could be designed. The first 
component of the modifications was the spring loaded mechanism. This mechanism is composed 
of three components (listed in appearances from left to right in the figure below): the platform, 
the four springs, and the housing.   
  
Figure 35. Spring loaded mechanism 
 
 The mechanism housing consists of a hollow cylinder designed to fit on top of the 
bottom cap of the middle insert. It contains a set of four pegs to hold the springs in place, and is 
capable of encapsulating both the springs and the platform. 
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Figure 36. Solidworks model of housing (no springs) 
 
 
Figure 37. Solidworks model of housing (with springs) 
 
The platform component is to fit snugly within the housing when the mechanism is under 
full compression, but is then used to provide a base off of which the springs can drive the middle 
insert upwards upon opening the bioreactor. It consists of a hollow cylinder with pegs similar to 
the housing in order to ensure the stability of the springs. Additionally, given that this component 
will be the main stress bearing feature of the spring mechanism, the stresses imparted onto the 
platform were calculated. 
Given that the spring mechanism will not be used to lift or manipulate the insert, it only 
bears the compressive force applied by the springs when the insert is under compression. In order 
to calculate the compressive stress that the platform will undergo, the load bearing surface area 
was calculated using the Solidworks measuring tool and determined to be 259.15mm2. With this 
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information, alongside the force calculated for the compressive force exerted by the springs, the 
compressive stress in this part can be found using the following equation: 
 
σc = Fs/As                  (9) 
 
Where σcis the compressive stress, Fs is the force exerted by all four springs, and Asis the load 
bearing cross sectional surface area of the platform. The compressive stress without the safety 
factor was calculated to be 52.054 kPa, and 2.934 MPa with the safety factor taken into 
consideration. Both values are comfortably below the 170 MPa yield stress of 316L stainless 
steel. 
 The second modification made to the insert was the inclusion of a handle on the top cap. 
This handle would be the piece that protrudes above the glass cylinder once the reactor is 
opened, allowing for the insert to be removed easily. The component was designed fit the 
curvature of the glass tube in order to limit its effect on the fluid flow of the system, as well as 
provide a structure that could be easily lifted with either forceps or a glass rod. The design 
consists of a ring handle mounted on two curves supports, as shown below: 
 
    
Figure 38. Modified insert cap with handle 
 
 This handle would need to withstand both tensile and compressive stresses, therefore 
both types of stress were calculated for each support using equation (9), substituting for the 
tensile force when applicable. The cross sectional load bearing surface area of each support was 
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calculated once again through SolidWorks and determined to be 16.11mm2. The results are 
presented in the table below: 
 
Table 12. Handle stress calculations 
 Compressive Stress (MPa) Tensile Stress (MPa) 
Without x50 safety factor 829.9kPa 276.1kPa 
With x50 safety factor 20.934MPa 6.905MPa 
 
 Finally, a hinge was added in order to attach the bottom end piece to the bioreactor base 
while also allowing it to swing forward in order to remove the insert. The hinge was designed 
using two nested brackets and a pin, as shown below: 
 
 
Figure 39. Outer hinge bracket 
 
 
Figure 40. Inner hinge bracket 
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Figure 41. Hinge Pin 
 
The hinge would be assembled and used to attach the bottom of the bioreactor to the base, as 
shown in Figure 34. 
 
Maintaining Fluid Flow Integrity 
In order to maintain the integrity of media flow through the perfusion system, all surfaces 
of contact should be coated in a bio-safe rubber film that will allow for a complete watertight 
seal when the insert is under compression. These surfaces include the top and bottom ends of the 
modified insert, as well as the exposed lips between the spring housing and platform. The 
surfaces mentioned are depicted in the image below: 
 
 
Figure 42. Rubberized insert surfaces 
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Overall Process 
 The overall process of removing the middle insert with the addition of both the modified 
insert caps as well as the hinge joint is depicted in Figure 32 above. It begins by disconnecting 
the bioreactor from the fluid system and placing it under a fume hood. This is followed by the 
loosening of the rear bolts that secure the top end piece, and sliding the end piece upwards in 
order to release the spring mechanism. The top end piece is then secured, and the reactor is 
leaned forward enough to remove the middle insert. It is then recommended that a sterilized tool, 
such as forceps or a glass rod slipped under the handle ring should be used to lift the insert out of 
the chamber. This will eliminate the need for human contact with the insert, reducing the risk of 
contamination. Additionally, the rubberized surfaces of both the handle and the spring loaded 
mechanism should create a watertight seal between both the chamber and the insert, as well as 
within the spring housing. This should maintain fluid flow, as well as secure the insert in a fixed 
position within the chamber.  
6.3 Industry Standards 
When designing the bioreactor system, it was important to consider the following 
standards/regulations when it comes to working with bioreactors and living cells. These 
standards were essential in determining the possible ways to achieve our goal and also in 
determining the success of the final design. A summary of the standards considered with the 
fabrication of the novel bioreactor are shown in Table 13 below: 
 
Table 13. Industry Standards Considered in Design 
ISO 11737 Sterilization of Medical Devices: Microbiological Methods, Part 1 
— Determination of a Population of Microorganisms on Products 
ASTM F1980:2007 Standard Guide for Accelerated Aging of Sterile Barrier Systems for 
Medical Devices 
ISO 13845:2016 Medical devices - Quality management systems - requirements for 
regulatory purposes 
ISO 10993-5:2009 Biological evaluation of medical devices — Part 5: Tests for in vitro 
cytotoxicity 
FDA 21CFR866:2018 Title 21,  Subchapter H, Part 866 - Cell and Tissue Products 
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The first standard that was considered was ISO 11737 (Sterilization of Medical Devices: 
Microbiological Methods, Part 1 — Determination of a Population of Microorganisms on 
Products) [22]. Sterility is extremely fundamental for the operation of a bioreactor as 
contamination must be avoided before the bioreactor is inoculated with cells. As such, the 
sterility of our novel bioreactor will be in accordance with this standard [22]. The team designed 
the bioreactor system so that it was reusable, and so it must be sterilized in between uses. This 
standard can be used to determine the sterility of the bioreactor from use to use. The standard 
establishes the requirements for validation and control of sterilization, such as how to determine 
whether or not the reactor is sterile. If the bioreactor contains the same amount of 
microorganisms on it as before sterilization it is considered not sterile and must be re-sterilized 
and checked again. 
 The second standard that was considered was ASTM F1980:2007 (Standard Guide for 
Accelerated Aging of Sterile Barrier Systems for Medical Devices). This standard was used in 
terms of the sterility of the barrier system in the bioreactor [23]. It is essential that sterility is 
maintained over a prolonged period of time, as bioreactor operations can range from days to 
weeks. This standard addresses the accelerated aging theory, in which properties may change 
over time, affecting the proper function of a sterile barrier system. As stated previously, it is 
essential to ensure that the inside environment of the bioreactor is sterile when in use and no 
contamination will occur.  
The third standard that was considered was ISO 13845:2016 (Medical devices - Quality 
management systems - requirements for regulatory purposes). The design of the novel bioreactor 
needed to be in accordance with this standard [24]. This standard provided guidelines throughout 
the entire design process, from ideation to prototyping and final design fabrication, in order to 
ensure that the product’s function and quality sufficiently met the client’s requirements. The 
product must function the way it is intended and accomplish all parts of the revised client 
statement. As such, this standard was relevant to the design process.  
The fourth standard that was considered was ISO 10993-5:2009 (Biological evaluation of 
medical devices — Part 5: Tests for in vitro cytotoxicity) [25]. This standard is useful in 
determining the toxicity of a material, as it specifies various types of tests that can be performed 
in order to determine whether or not a material is toxic to cells when in use. This standard is 
important because the bioreactor could not introduce toxicity to the cells, as this would 
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compromise the function of the cells and the operation of the bioreactor. 
 The fifth standard that was considered was FDA 21CFR866:2018 (Title 21, Subchapter 
H, Part 866 - Cell and Tissue Products) [26]. These standards/regulations can be used when it 
comes to testing the bioreactor with live cells. These regulations help to define and specify many 
parts of the cell culture process such as culture medium, quality control kits, and microbial 
monitoring, which will be important in the operation and testing of the bioreactor system.   
6.4 Economic Impact 
The economic impact of the device lies in the microcarrier technology that is being used 
in the system. The novel bioreactor used glass beads as the microcarrier technology compared to 
the Cytodex bead technology that the control bioreactor uses. The glass beads are much more 
widely available and a fraction of the cost. One economic increase would be the cartridge that 
hosts the microcarriers. Although the system is reusable by simply re-sterilizing it, the cartridge 
that holds the microcarriers would be exchanged between uses and would therefore be an added 
ongoing expense after the initial purchase of the entire system. The entire device is made of 
affordable materials including stainless steel and glass and is able to be assembled in 
approximately two weeks, which would allow the user the ability to begin use in order to begin 
production quickly. An indirect economic impact would be the cost of labor for a person 
operating the bioreactor. The current method for adherent cell culture in a bioreactor requires a 
person to operate the system in the beginning stage to continuously start and stop the system in 
order to allow the cells to settle and attach to the microcarriers. This is no longer necessary with 
the novel bioreactor system, therefore eliminating additional manpower. 
6.5 Societal and Political Impact 
 The utilization of bioreactors within the greater context of the medical field may yield 
societal benefits as larger scale biomanufacturing may occur with the production of biologics to 
treat diseases or concerns. The optimization of adherent bioreactor technology would promote 
scalability, thereby allowing adherent bioreactors to eventually be utilized in these large scale 
productions. An example of this is the usage of bioreactors within tissue engineering 
applications, where the bioreactor acts to reproduce physiological conditions in order to promote 
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and maintain cell culture with tissue engineering applications. Bioreactors are extremely useful 
for tissue engineering with the creation of a 3D environment that is more physiologically 
relevant than a simple 2D adherent culture. One specific application for tissue regeneration is the 
utilization of bioreactors in research aimed at producing pancreatic progenitor cells for the 
treatment of patients with diabetes [40]. The growth of tissue engineering will have a massive 
impact on the medical field, and on society in general, with the great potential to augment, 
maintain, or recreate functions within the body which may have been lost or negatively impacted 
due to disease, trauma, or medical conditions.  
 The potential impact on politics can be regarded with two different perspectives: in the 
context of politics within companies and in the context of consumerism and market regulations. 
Typically within companies, medical pursuits involve politics as economic profit and gain are 
always considerable factors with the development of technologies. Although a medical device or 
product may be extremely beneficial, politics can dictate whether or not the technology is 
developed or pursued if it is too costly. The utilization of an economically viable adherent 
bioreactor such as our design may help to alleviate these types of cost-benefit analysis if the 
price of large scale biomanufacturing can be mitigated. Additionally, political impact in terms of 
market regulations should be considered as well. One specific application of bioreactors is the 
creation of lab cultured meat, which is particularly useful in replacing current sources for meat 
while also mitigating environmental impact in its production. The politics regarding the 
production and marketing of lab cultured meat is important as large regulatory bodies such as the 
FDA will have to be heavily involved in ensuring proper safety and efficacy [41]. This is 
applicable to any medical product created utilizing bioreactors, as the FDA or other regulatory 
entities will have to be involved to ensure the product is able to be marketed.  
6.6 Environmental Impact 
 The two main materials utilized in the fabrication of the bioreactor is 316 stainless steel 
and borosilicate glass. These materials should have minimal impact on the environment, thereby 
mitigating the potential environmental impact our device may have throughout its fabrication 
process and afterwards if it is disposed of. Stainless steel is considered an environmentally 
friendly product as it is 100% recyclable, while it also typically lacks coatings that could 
potentially be environmentally toxic if it leeches. During the production phase, stainless steel is 
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typically made from raw material, with up to 70% of the material being produced from recycled 
material [42]. Borosilicate glass should not have any notable environmental impact as well, 
however one aspect to note is its potential human impact during the production phase. 
Borosilicate glass is made from crystalline silica, and during its production crystalline silica is 
considered a health and disease risk if large amounts are inhaled. However, typically 
manufacturing facilities have proper policies and protective equipment in place to help mitigate 
these risks [43]. 
6.7 Ethical Concerns 
 Given that the product of our design is aimed towards adherent cell culture, this can 
eventually be translated into stem cell research and stem cell therapy, and therefore it is 
important to mention the ethical concerns pertaining to our project. Stem cell research can be 
controversial because it can involve the utilization and harvesting of human embryos. Since our 
device has no part in the development of stem cells, we do not foresee any ethical issues with the 
creation and use of our design. 
6.8 Manufacturability 
Utilizing the given schematics and SolidWorks drawings, the bioreactor system can be 
reproduced as long as the correct materials are utilized, which can be found in Appendix B: Bill 
of Materials, with the specific suppliers utilized for any specific components. Everything was 
purchased or manufactured in a reasonable time frame, while staying significantly under the 
$1,000 MQP budget.  
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Chapter 7: Discussion 
This project was designed to create a novel bioreactor system capable of enhancing cellular 
attachment and confluency in comparison to current adherent bioreactor systems. Achieving this 
goal would help to generate higher final cell densities, thereby supporting larger-scale adherent 
cell operations. Several preliminary experiments were run, which highlighted that the objectives 
of optimizing cell attachment and creating a continuous flow were achieved.  
7.1 Volumetric Efficiency Comparison 
As shown in Section 5.1 Volumetric Efficiency Comparison, our novel system is found to 
be 6.5-times more volumetrically efficient assuming 100% confluency in both systems. With the 
assumption of 100% confluency, this increase in volumetric efficiency represents the upper 
possible limit. It is likely that the cells within both systems will not fully reach 100% confluency, 
and so it will be likely that the increase in volumetric efficiency is actually smaller than 6.5-
times, however if both systems were utilized until they could no longer support any more cell 
proliferation, the number of cells in the novel system will be significantly higher if this system 
has the same volume as the Cytodex system. Therefore, this demonstrates the feasibility of 
higher final cell densities in the packed bed bioreactor when both systems are used at the same 
volume, with the maximum possible increase being 6.5-times.  
The main reason for this efficiency is that the packed bed will allow cells to migrate 
between microcarriers, something that is extremely difficult when the microcarriers are in a 
stirred tank bioreactor. The Cytodex system is not volumetrically efficient due to the fact that 
only a specific number of microcarriers can be supported per unit volume of the bioreactor, and 
these microcarriers are widely spread apart with dead space between each microcarrier due to the 
homogeneous mixing of the system. In comparison, the packed bed bioreactor minimizes the 
dead space between microcarriers, allowing for significantly smaller bioreactor volumes which 
would contain the same amount of microcarriers as the Cytodex system. As such, smaller 
bioreactor volumes would be needed to achieve the same number of cells as the Cytodex system 
since the system is more volumetrically efficient. This packing and cellular migration supports 
greater amounts of cells in smaller bioreactor volumes. 
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7.2 Microcarrier Optimization 
The glass beads that were not modified resulted with cells congregating mostly in the 
spaces between the beads rather than on the surfaces of the glass beads. This can be seen in 
Figure 7. The gelatin coated glass beads did show some cells on the surfaces of the beads. 
However, the amount of cells on the beads was less than that of the control Cytodex 
microcarriers due to the difficulty of the coating process. The wide dispersity of the cell 
placements on the glass surface could be contributed to the fact that the gelatin coating was 
difficult to administer so the beads were unable to receive an equal coating throughout. The 
gelatin coated glass beads can be observed in Figure 8. The plasma Treated glass beads showed a 
much more even distribution of cells on the entire surface of the beads. This modification also 
displayed some bead to bead migration from cells. The oxygen plasma Treatment was able to be 
fully dispersed onto the entire surface of the bead allowing in even dispersion of the cells on 
those surfaces. The cells can be seen on the plasma treated glass beads in Figure 9. The image 
comparisons from the Cytodex to the plasma treated glass beads show more cells distributed 
throughout all layers of the bead surface as well as bead-to-bead migration of the cells on the 
glass beads that is not seen in on the Cytodex microcarriers. 
7.3 Ergun Equation and Oxygenation Calculations 
The calculations shown in Section 5.3 highlight that theoretically, the novel bioreactor 
system is capable of supporting adherent cell culture. This is due to the fact that for packed beds 
with a volumetric flow range of 30-75 mL/min, the calculated pressure drops across the packed 
bed were very small and almost negligible, ranging from 870-2210 Pa. When compared to the 
172 kPa back pressure supported by the provided peristaltic pump, it is demonstrated that the 
pump would have been capable of supporting this range of flow rates since their associated 
pressure drops were extremely small in comparison. As such, theoretically the pump should be 
able to achieve continuous flow within the system, which is later confirmed with the preliminary 
fluid tests shown in Section 5.3. The associated shear stress with these volumetric flow rates was 
also calculated, ranging from 2.63 - 6.66 dynes/cm2. The shear stress limit of 6.5-10 dynes/cm2 is 
achieved when the flow rate within the system is 75 mL/min, with a calculated shear stress of 
6.66 dynes/cm2. The provided peristaltic pump runs at a flow rate of 56.8 mL/min, and therefore 
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should not create shear stresses that are significant enough to influence the morphology or 
metabolism of the cells, and should not rip off the cells from the microcarrier surfaces.  
Additionally, the bioreactor system should have been able to provide enough oxygen to 
support the adherent cells in the packed bed. This is confirmed when comparing the theoretical 
total oxygen consumption rates with the theoretical total oxygen delivery rates. For a volumetric 
flow rate range of 5-50 mL/min, the oxygen delivery rates of 3.33 - 33.3 x 10-4 mg/sec were 
significantly higher than the theoretical oxygen consumption rate of 1.07 x 10-4 mg/sec, thereby 
confirming that the bioreactor should be able to support the oxygen requirements of the cells in 
the packed bed since the flow rate of the provided pump is 56.8 mL/min. However, it should be 
noted that all these calculations are simply theoretical. Unfortunately, due to circumstances 
surrounding COVID-19, the team was unable to examine adherent cell cultures in the novel 
bioreactor system, and therefore was unable to confirm that the cells were capable of being 
supported.  
7.4 Bioreactor Fluid Test 
 The fluid test with the final design confirmed that no leaks were present in the bioreactor 
system and that continuous flow was achieved. This continuous flow is significant because it is 
the main mechanism behind seeding the cells onto the microcarriers in the packed bed, while 
providing nutrients, oxygen, and any unattached cells so that they have the opportunity to adhere 
to microcarriers in the system. One important observation was the fact that when the fluid test 
was run, it was observed how green dye built up around the middle insert. Ideally, there should 
be no fluid movement around the middle insert containing the beads, since the media should be 
directed through the end pieces and up into the middle insert. However, the presence of green 
dye around the insert highlighted that this was not the case. This is due to the fact that the glass 
tubes purchased were not perfectly uniform in the inner diameter across their lengths. Due to 
this, during the manufacturing process the outer diameter of the middle insert could not have 
been manufactured exactly to match the inner diameter of the tubing. If this was possible, this 
would allow the middle insert to simply be press-fit into the tube, naturally creating a water-tight 
seal so that the media would only be capable of moving through the middle insert rather than 
around it. This was an inherent limitation with the purchased glass tube, and as such should be 
something that is improved upon in the future. The ability of the media to build up around the 
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middle insert may impact the continuous flow of unattached cells, as it is possible for cells to 
instead build up around the middle insert instead of flowing through the packed bed. However, 
besides this limitation, the fluid test confirmed that the objective of continuous flow was 
achieved.  
7.5 Novel Bioreactor Comparison Study 
Unfortunately, a comparison study was not able to be conducted due to circumstances with 
COVID-19. As a result, there is no concrete data on whether or not the novel bioreactor would 
have been capable of supporting adherent cell culture in an enhanced manner in comparison to 
the current bioreactor system. The following section will thereby discuss the expected results of 
this study. 
7.5.1 Nutrient Tests 
 The generation of nutrient curves would have allowed comparisons between the current 
intermittent stirring bioreactor system and the novel bioreactor system. It would be expected that 
both contain similar nutrient curves, comparable in terms of trends to the sample nutrient curve 
given in Section 5.5.1. However, deviations from between the two curves would potentially 
indicate differences between the two bioreactor systems, which is the expected result. For 
example, if the novel bioreactor was capable of supporting enhanced attachment efficiencies, this 
would result in higher cell densities. Due to this, nutrient depletion and waste generation would 
be faster corresponding to these higher cell counts, resulting in a nutrient curve with more 
exaggerated trends in comparison to the adherent intermittent stirring system.  
 One important aspect of this test would have been the utilization of a control, which 
simply would have been nutrient testing of the cell culture in a regular T-flask. These baseline 
nutrient curves would establish how nutrient depletion or waste generation typically trends in a 
normal adherent culture before being translated into a bioreactor system. These trends can then 
be related to observed cell population doubling by observing the relative confluency of the cell 
culture. As such, trends in nutrient levels can be corresponded to cell doublings, establishing 
expected percentage increases or decreases whenever the population doubles. Ideally, these same 
trends would be observed within the bioreactors, however as previously stated, it is expected that 
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the novel bioreactor would have experienced higher cell densities. As such, it would have been 
possible to extrapolate information on cell doubling and cell growth within the novel system 
based on the generated nutrient curves and how the percentage increases or decreases would 
have compared to the control nutrient curves. It would have been expected for the cell doubling 
to still remain approximately 24 hours, however the team would have been able to observe when 
these doublings occurred, helping to characterize growth within the bioreactor and how cell 
growth compared with the Cytodex bioreactor.  
7.5.2 Final Cell Densities  
 The final cell density test between the novel bioreactor system and the current 
intermittent stirring system would have compared cell attachment efficiency. From the 
microcarrier comparison study it is expected that the novel bioreactor system would have 
allowed bead to bead migration of cells, which is not currently achieved by the intermittent 
stirring system. This bead to bead migration would have resulted in higher cell densities for the 
novel bioreactor system because the beads had more surface area for cells to attach to and grow 
on. Also from the volumetric efficiency calculations between the two bioreactor systems it would 
have been expected that the novel bioreactor system would have an expected 6.5-fold increase 
allowing for a larger area for cells to adhere to. This could potentially result in 6.5 times more 
cells compared to the current state of the art system. A higher attachment efficiency of the novel 
system would allow for a potential increase in production of cells using a bioreactor system.  
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Chapter 8: Conclusions & Recommendations 
With the final bioreactor system being constructed, several objectives were achieved with 
the end goal of improving adherent efficiency and viable cell densities for adherent cell 
bioreactor systems. First, optimization of microcarrier cell attachment was achieved through the 
examination of various microcarrier materials and demonstrating the possibility for bead to bead 
migration with cells in a packed bed system. The team was able to perform the glass bead 
attachment experiment comparing Cytodex 1 beads and glass beads with various surface 
modifications in static culture. The experiment proved that at the very least glass beads modified 
with gelatin and plasma treatment were comparable to the Cytodex 1. The plasma treated glass 
beads showed a more unified distribution of cells on the entire surface of the glass bead 
compared to that of the gelatin treated beads. This was most likely due to the difficulty of 
uniformly treating all areas of the glass beads with gelatin. The plasma treated glass beads 
showed the migration of cells from one bead to another bead in order to increase the surface area 
the cells were limited to grow on. The migration of cells could result in higher cell densities 
because they are not limited to the surface area of just one bead, as is for the current state of the 
art system. 
Afterwards, with the bioreactor being constructed, continuous flow was demonstrated as 
feasible with the system. This continuous flow is important because it would theoretically help to 
meet the objective of increasing attachment efficiency through the recycling of unattached cells 
within the closed-loop system. Additionally, the various verification calculations demonstrated 
that the flow created by the peristaltic pump would not have generated a significantly high shear 
stress on the cells, and the system should have been able to provide sufficient oxygenation for 
the cells. Unfortunately, the team was unable to examine the performance of the bioreactor with 
cells, and therefore was unable to demonstrate whether or not the bioreactor was capable of 
enhancing cellular attachment in comparison to the current intermittent stirring adherent system. 
This would meet the objective of promoting maximum confluency by allowing cells to migrate 
onto microcarriers which previously did not contain any cells from the initial seeding process. 
Volumetric efficiency was demonstrated with the novel bioreactor as calculations highlighted 
that our packed bed bioreactor achieves a 6.5-fold increase in volumetric efficiency in 
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comparison to the Cytodex microcarrier system.  This is significant as it would allow for higher 
cell densities to be achieved in lower amounts of volume. 
In terms of limitations, one important limitation was discovered through the fluid test, 
which demonstrated how fluid is capable of flowing around the middle insert rather than solely 
be directed through the packed bed. This was due to the fact that the glass tube purchased for the 
project was not perfectly uniform in its inner diameter along its length, and therefore the middle 
insert could not have been designed to be the exact inner diameter of the glass tube, which would 
have allowed the insert to be press-fit into the tube. This should be taken into consideration in 
any future work, and any glass tube utilized in recreating this system should either have a 
constant inner diameter or should be manufactured independently in order to ensure a proper fit 
with the middle insert and the glass tube. Another limitation for the design was the utilization of 
the incubator in GH 006. There are a wide variety of incubators with varying sizes, and the 
incubator available for the team was on the smaller side. As a result, the incubator could not be 
manufactured to the size of regular benchtop bioreactors, and was restricted to the size of the 
small incubator. If possible, a larger incubator should be utilized for the bioreactor so that it is 
not limited in terms of height and size, which may allow for more optimal packed bed lengths.   
 In terms of future work, there are several recommendations that the team suggests. The 
team suggests that the comparison study be completed following the protocol in Appendix D: 
Protocols titled Bioreactor Comparison Test. This would allow for the novel system to be tested 
in order to show the possible impact it may have on adherent cell culture.  
 The insert in which the glass beads are packed was unable to be made see-through due to 
time and manufacturing restrictions. It is suggested that the manufacturing process be modified 
in order to allow the insert to contain a hole in which the user can observe and image the cells on 
the beads. This would allow for the packed bed to be imaged without taking the system apart and 
therefore stopping and contaminating the system. 
 An additional recommendation would be to test different cell lines in the system with the 
plasma treated glass beads. This would allow for a validation of the system in terms of how it 
works with other forms of adherent cells. The cells that were used in the static culture 
experiment were human dermal fibroblast cells and it would be assumed that other adherent cell 
lines would produce similar results in terms of attachment. 
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 A final recommendation would be to optimize the bioreactor design. In terms of 
optimizing the design, it would be ideal to make the reactor incubator-independent like most 
current benchtop bioreactors. This would involve adding a thermal jacket for temperature 
regulation, an oxygen supply for proper culture oxygenation, and nutrient supply for the system. 
The reactor may also be modified to interface with process control sensors like current benchtop 
bioreactors so that temperature, pH, and oxygen can be directly measured. Additionally, the 
scalability of the bioreactor should be confirmed with the manufacturing and testing of larger-
sized models to ensure that in the end, this bioreactor design will be capable of supporting larger 
biomanufacturing processes. 
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Appendix 
Appendix A: Interviews with Chris Bellerive 
 Throughout the course of the project, we had met with Chris Bellerive from WPI’s 
Biomanufacturing Education and Training Center, who had served as our client to provide 
insight into the current biomanufacturing industry, the current state of the art, and limitations 
associated. The questions are provided below along with a paraphrased version of Chris’s 
answers. 
  
Meeting 1 - November 12, 2019 
Q: What are the existing issues with the microcarrier system of GE Cytodex beads? 
A: The challenging issue is trying to attach cells onto the microcarriers within the stirred tank 
bioreactor. Some cells are capable of attaching while others are not. So the current issue right 
now is how do we increase efficiency? During the intermittent stirring process, ramping up the 
agitator can potentially strip cells off the beads that are already attached. Ideally, the shears 
shouldn’t rip off cells while also maintaining mixing. Additionally, there is the issue of utilizing 
surface area to increase the amount of cells that attach versus those that do not. Maybe there 
could be a way to create a system that would create more surface area? For example, what if the 
microcarriers are able to lock together, thereby creating more surface area to help attach cells and 
provide more surface for the existing attached cells to continue to grow. 
 
Q: Why utilize the microcarriers instead of using other forms of scaffolding? 
A: There really isn’t anything out there for larger scale bioreactor, mainly just the microbeads. A 
potential idea could possibly be creating a scaffold, maybe with an adjusted impeller design, so 
that lower shears would avoid stripping cells, while the scaffold would offer a large surface area 
for cells to attach to.  
 
Q: What are the challenges and effects of shear stresses? 
A: There currently isn’t too much information out on shear forces within the bioreactor system. 
Ideally, you cannot have high shear as this would be damaging to cells. However, there are 
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already optimized impeller designs such as pitched blade designs that aim at helping with issues 
surrounding shear force. Shear isn’t much of an issue for current suspension cells, however it 
would be very useful to look at for adherent cells, such as stem cells or those that are more shear-
sensitive.  
 
Q: What do you use to quantify various nutrients and metabolites in the media? 
A: We utilize a Cedex reader which contains optical sensors and assays which contain enzymes 
and reagents to measure this type of data from cell media. These systems are “off-line”, meaning 
that they are separate from the bioreactor system and a sample from the bioreactor must be used 
each time. We look at cellular byproducts such as ammonia and lactate. These are main concerns 
that need to be looked at since high concentrations would make them toxic to the culture. You 
could also look at Lactate dehydrogenase as an indicator of viability. We also look at nutrients 
such as glutamate and glutamine.  
 
Meeting 2 - March 6, 2020 
Q: What does the BETC utilize as bottles for their flasks and benchtop bioreactors? 
A: For media bottles, the BETC utilizes caps from ChemGlass, which have ports on them to 
attach tubing onto. There are a variety of designs with a varying number of ports. Maybe your 
group can start with the designs that have 3 or 4 ports. 
 
Q: What are the specific concentrations of Cytodex that the BETC utilizes for their 
bioreactor operations? How do you determine what initial seeding density you will utilize? 
A: For our Cytodex bioreactors, we typically utilize 3-7 grams of Cytodex per liter of volume 
within the bioreactor in our previous experiments. In terms of the seeding densities, the initial 
density will be dependent on the size of the cells, the surface area of the beads, and the doubling 
times of the cells. 
 
Q: How would you approach gathering nutrient data and what kind of data can we gather 
from this? 
A: You should look into nutrient depletion within bioreactors, as you may be able to determine 
cell growth and extrapolate the doubling time and growth rate from these. For example, you 
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could start with a control study where you determine the nutrient uptake of the cell line in a 
normal T flask. Then, you could look at this data and use it as a baseline for the bioreactor 
nutrient depletion.  
 
Q: How would we quantify the nutrient uptake? 
A: You can utilize glutamax, ammonia, and lactate assays, among the other nutrients you would 
want to look into. These can all be done with the Roche Cedex machines here in the Cedex.  
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Appendix B: Bill of Materials 
Material Cost (USD) Manufacturer 
Cytodex I beads (25g) 335.00 Sigma-Aldrich 
Megalux Uncoated Glass 
Beads 30/40 Mesh 
N/A (sample provided by 
manufacturer) 
Swarco 
Glutamax (100 mL) 37.17 Gibco 
DMEM (500 mL) 26.22 Gibco 
FBS (50 mL) 65.50 Sigma-Aldrich 
Penicillin/Streptomycin (100 
mL) 
25.00 Sigma-Aldrich 
Cells (HUVEC/Fibroblast) 
(106 cells) 
279.00  
316L Stainless Steel 5.77-6.35 per kg N/A (supplied by Tom 
Partington)  
Manostat E-series Economy 
Peristaltic Pump 
Discontinued Cole-Palmer 
Pyrex Reusable Media 
Storage Bottle - 1L  
194.94 / case of 10 Fisher Scientific 
ChemGlass 3-Port Assembly 
for 1L Media Bottle 
$326.98 ChemGlass 
38.1mm (1 1/2 in) O.D. 
Corning Pyrex Glass Tubing 
$29.95 (2 pcs)  Wale Apparatus 
Precision Stainless Steel Wire 
Cloth - 316 Stainless Steel - 
50 x 50 Mesh Size 
$23.27 (12”x12” sheet) McMaster-Carr 
5 mm Inner Diameter 
Polyurethane Tubings 
N/A N/A (supplied from GH 207 
lab)  
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Appendix C: Bioreactor Components 
 This appendix will break down each of the bioreactor components found in the system 
and the material they are made of. The main bioreactor system consists of three main 
components: 
1. The bioreactor vessel 
2. The Manostat E-series Economy Peristaltic Pump 
3. The media reservoir with bottle cap ports 
 
The bioreactor vessel consists of five parts: 
1. A base mount made of 316 Stainless Steel with screws to hold the bioreactor vessel 
vertically 
2. A bottom end piece made of 316 Stainless Steel, acting as the inlet for the system as it is 
connected to the pump via tubing. This end piece also contains an O-Ring inside of it to 
create a water-tight interface with the borosilicate glass tube 
3. A top end piece made of 316 Stainless Steel, acting as the outlet for the system as it is 
connected to the outlet port on the media reservoir via tubing. This end piece also 
contains an O-Ring inside of it to create a water-tight interface with the borosilicate glass 
tube 
4. A middle borosilicate glass tube in between each of the end pieces, acting as a chamber 
to contain the middle insert 
5. A middle insert made of 316 Stainless Steel that is situated inside the glass tube, acting as 
the chamber to hold the packed bed of microcarriers 
 
The middle insert is also composed of three separate components: 
1. A top end piece that is screwed onto the middle insert. This top piece will contain a 316 
Stainless Steel mesh to prevent the flow of microcarriers from the packed bed out of the 
middle insert. This end piece also contains an O-Ring inside of it to create a water-tight 
interface with the middle insert  
2. A bottom end piece that is screwed onto the middle insert. This bottom piece will contain 
a 316 Stainless Steel mesh small enough to contain the packed bed of microcarriers. This 
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end piece also contains an O-Ring inside of it to create a water-tight interface with the 
middle insert  
3. The middle insert itself, with threaded ends on the top and bottom which will allow the 
end pieces to be screwed onto it  
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Appendix D: Protocols 
Title: Adherent Cell Culturing Protocol 
 
 
1. Scope and Purpose 
 
The purpose of this protocol is to detail how to properly subculture adherent cells with the 
transfer of the current cell culture into one with fresh growth media. This protocol can be utilized 
universally with minor changes to either the complete medium or the volumes used depending on 
the specific cell line. In the context of this MQP, this protocol is used to subculture the cells 
before being utilized in any preliminary verification study or before being transferred into the 
bioreactors. 
 
2. Materials 
 
- 5 mL DPBS (-) 
- 3 mL 0.25% Trypsin-EDTA 
- At least 15 mL complete growth medium 
- Incubator (37℃, 5% CO2) 
- 5 mL & 10 mL serological pipettes 
- Pasteur pipettes 
- Vacuum pump 
- Microscope 
- Centrifuge 
 
3. Procedure 
 
1. Before bringing the current culture plate with cells into the hood, check culture plate 
under the microscope to 
a. Check the health and degree of confluency of the cells 
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b. Ensure that cells are not contaminated 
2. Bring plate inside hood 
3. Attach sterile Pasteur pipette to tube attached to vacuum pump, carefully aspirate 
medium 
4. Using serological pipette, gently add 5 mL DPBS (-) alongside of plate, rinse cells 
5. Attach Pasteur pipette to tube attached to vacuum pump, carefully aspirate DPBS (-) 
6. Using serological pipette, gently add 3 mL of 0.25% Trypsin-EDTA solution along the 
side of the plate, Close the lid 
7. Incubate the plate on slide warmer at 37C for 5-10 minutes 
8. After incubation, check the cells under the microscope to make sure that cells are 
detached and loose, bring the plate inside the hood 
9. Using fresh serological pipette, add 2 mL complete medium to the plate. This 
neutralized the trypsin, the total volume is now 5 mL 
10. Using same serological pipette, disperse cells by repeated pipetting, avoid air bubbles 
11. Transfer cell suspension to fresh, sterile 15 mL conical tube, repeat pipetting to break up 
cell clumps 
12. If you plan on doing a cell count, you can use a sample of cell suspension at this 
point 
13. Spin the tube at 200G for 5-10 minutes in the centrifuge, after centrifugation, look for the 
cell pellet at the bottom of the tube 
14. Using the vacuum set up, carefully aspirate the medium using a fresh sterile Pasteur 
pipette leaving about 0.5 mL fluid in the tube 
15. Resuspend cells in an appropriate amount of complete media, depending on ratio of 
subculturing (1:3, 1:4, 1:5, 1:10) or plate specific amount of cells as needed for 
experiment. A good rule of thumb if you counted the cells is to resuspend the cells at 1 
million cells/mL 
16. Plate enough cells into a fresh plate, making the total volume of medium to 10 mL (if you 
are plating 1 mL cells, add 9 mL complete media) 
17. Check cells under microscope 
18. Transfer plate to incubator for continued incubation for desired duration 
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4. Definitions  
 
Confluency - Percentage of the surface of the culture dish covered by the adherent cells 
Complete Media - Growth media made previously consisting of Dulbecco’s Modified Eagle 
Media, Penicillin/Streptomycin, Fetal Bovine Serum, and Glutamax 
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Title: Microcarrier Attachment Experiment Protocol 
 
 
1. Purpose 
The purpose of this protocol is to detail a preliminary microcarrier attachment experiment 
examining cellular attachment and bead to bead migration on a variety of microcarrier substrates. 
This includes the Cytodex 1 microcarriers from General Electric, as well as glass beads subjected 
to various surface modifications. This experiment will help to determine the best microcarrier 
substrate available to the group before translation into the bioreactor system. The protocol will 
go through the various preliminary steps of sterilization and applying surface modifications to 
the glass beads before culturing with cells.  
 
2. Materials 
- Cytodex 1 microcarriers from GE 
- DPBS 
- Forceps 
- Scooper 
- 70% Isopropyl alcohol 
- Plastic mesh  
- Megalux glass beads 30/40 mesh 
- 0.1% Gelatin Solution (ATCC® PCS-999-027™) 
- Plasma Cleaner in SL 219 
- Complete Medium 
- Incubator (at 37℃ and 5% CO2) 
- Phase contrast microscope  
 
3. Procedure 
Sterilization 
1. First must sterilize forceps, scooper 
2. Add into tubes of isopropyl alcohol for 1 minute 
3. Rinse by moving items into tubes of DPBS 
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4. Repeat several times for several rounds of sterilization 
5. Must also sterilize plastic mesh to be used to move glass beads to be coated in gelatin 
6. Repeat steps, however soak mesh in petri dish of isopropyl alcohol instead of a tube 
7. Place glass beads in autoclave bag and send to lab manager for beads to be autoclaved 
 
Gelatin Coating 
1. Decontaminate the external surface of the 0.1% Gelatin Solution bottle by spraying with 
70% ethanol. 
2. Using aseptic technique and working in a laminar flow hood or biosafety cabinet, add 1.0 
mL of 0.1% Gelatin Solution per 10 cm2 of culture surface area (e.g., 2.5 mL if using a 
T-25 flask).  
3. Using forceps, place sterilized mesh which contains autoclaved beads into dish 
4. Rock culture flask to coat the surface; place in a 37°C incubator (with or without 5% 
CO2) for at least 30 minutes, and up to overnight. 
5. Using forceps, remove sterilized mesh and the coated beads from dish into new dish 
6. Add 5.0 mL of complete growth medium per 25 cm2 of culture surface area (e.g., 5.0 mL 
if using a T-25 flask). 
7. Place the gelatin-coated beads in a 37°C, 5% CO2 incubator for at least one hour to 
equilibrate before inoculating with the cell suspension.   
 
Plasma Treatment 
1. Place autoclaved glass beads into a 60 mm plate and place the plate inside the plasma 
cleaner in SL 219  
2. Turn the plasma cleaner on, then the vacuum on 
3. Place the cap over the entrance and turn the black dial to seal the entrance 
4. Turn the dial on the plasma cleaner to high and ensure the plasma cleaner is on by 
checking the side for a purple flame. Duration of the plasma cleaning should be 1-2 
minutes 
5. Turn everything off, and slowly release the black dial to take off the cap 
6. Take plate out and lightly shake in an effort to turn over the glass beads in the plate  
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a. Plasma treatment only affects the top exposing layers, therefore this shaking will 
attempt to expose any surface that may not have been exposed in the first plasma 
treatment 
7. Repeat steps 1-5 
8. Remove plate with beads, cover and bring to the hood 
 
Glass Attachment Experiment 
 
1. Using the 24 well plate template below, place the appropriate microcarriers into their 
corresponding columns 
a. The microcarriers are transferred into each well by utilizing the sterilized scooper 
to scoop autoclaved glass beads, modified glass beads, and Cytodex beads until 
the bottom layer of the well is completely covered 
b. A1, B1 and C1 will contain the control (no beads in the well, simply adherent 
cells seeded on the well surface) 
c. A2, B2, and C2 will contain Cytodex 1 beads 
i. Refer to Control Bioreactor Protocol steps 1-5 for preparing and swelling 
the Cytodex 1 microcarriers 
d. A3, B3 and C3 will contain glass beads (unmodified) 
e. A4, B4, and C4 will contain the gelatin-coated glass beads 
f. A5, B5, and C5 will contain the plasma-treated glass beads 
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2. Seed ~4000 cells into each well (refer to the Cell Subculturing Protocol on how to plate 
cells from a subculture) 
3. Fill each well with up to 2 mL of complete medium 
4. Take initial images of each well under phase contrast microscope and note when T=0 is 
5. Place 24 well plate into incubator at 37℃ and 5% CO2 
6. Check and image each well at T=6 and T=16 hours 
7. After T=16 hours, refer to the Hoechst Staining Protocol in order to fluorescently image 
each well 
 
 
4. Definitions 
 
N/A 
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Title: Hoechst Cell Staining Protocol 
 
 
1. Purpose 
 The purpose of this protocol is to take video and images of cells that are adhered to 
microcarriers using fluorescence microscopy in order to show cell growth and migration in static 
microcarrier culture. During this experiment Hoechst Dye was used in order to image cell nuclei 
on microcarriers. 
 
2. Materials 
- Hoechst Dye 
- 24-well plate with microcarriers and cells from microcarrier experiment 
- Metal Scoop 
- Fluorescence microscope 
 
3. Procedure 
1. First, Hoechst dye was obtained from the lab 
2. Next, 2 uL of Hoechst dye was added directly to each of the 5 wells which need to be 
imaged, each containing 2 mL of culture media, in order to achieve a 1ug/mL final 
concentration 
3. Mix the dye/media solution via repeated pipetting  
4. After, wells were put in an incubator at 37 degrees Celsius for 10-15 mins to allow the 
dye diffuse through the cells 
5. After letting the wells sit, the beads in each well were carefully transferred to 
corresponding empty wells to ensure only the cells on the microcarriers are being imaged. 
This was done using a sterilized metal ‘scoop’.  
6. Finally the wells were put under a fluorescence microscope in order to take video and 
images of the cells at different cross-sections of the beads 
 
4. Definitions 
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Hoechst dye - Nucleic acid stain that emits blue fluorescence when bound to double stranded 
DNA 
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Title: Novel Bioreactor Setup and Breakdown 
 
 
1. Purpose 
The purpose of this protocol is to detail the steps in setting up the bioreactor so that it is ready for 
the preliminary fluid test or the final comparison study. It is necessary to understand the naming 
of each component (refer to the Final Design section) and how they come together to comprise 
the final bioreactor design. Breakdown of the bioreactor will also be necessary at the end of the 
study for conducting final cell density comparisons 
 
2. Materials 
- Novel bioreactor components (listed in the Final Design section) 
- Manostat E Series Economy peristaltic pump 
- 5 mm ID polyurethane tubing 
- Megalux glass beads 30/40 mesh (plasma treated modification) 
- 1 L media bottle 
- ChemGlass 3-Port Assembly for 1 L media bottle 
 
3. Procedure 
Bioreactor Setup* 
1. Insert the glass tube into one of the stainless steel end pieces containing the appropriate 
O-ring, twisting and applying force so that the tube pops into place 
2. Screw off the top cap of the middle insert and scoop in required amount of glass beads 
into the insert; screw the top cap back onto the middle insert and place the middle insert 
inside the glass tube 
3. Repeat step 1 with the other stainless steel end piece, closing off the top of the glass tube 
so that both ends are now in place with each steel end piece 
4. Line up the back ends of the steel end pieces so that the screw holes on each back end is 
facing the screw holes on the base mount 
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5. Place washer around a screw and insert into one of the aligned screw holes of the base 
mount and one of the steel end pieces; use a flat-head screwdriver to screw the screw into 
place, make sure not to overtighten 
6. Repeat step 5 with the 3 other aligned screw holes so that the bioreactor is mounted onto 
the base mount 
7. Connect 5 mm ID polyurethane tubings onto the hose nipples on both the top and bottom 
steel end pieces 
8. Connect the bottom polyurethane tubing to the outlet port of the Manostat E Series 
Economy peristaltic pump 
 
Media Bottle Setup 
1. Fill the media bottle with 400 mL media 
2. Screw on the ChemGlass 3-port cap onto the media bottle 
3. Connect a 5mm ID polyurethane tubing from the inlet port of the media bottle to the inlet 
port on the Manostat E Series Economy peristaltic pump 
4. Connect the top polyurethane tubing of the bioreactor to the outlet port of the media 
bottle 
 
Bioreactor Breakdown* 
1. Remove the inlet polyurethane tubing from the inlet port on the media bottle and place it 
into empty flask within incubator 
2. Run pump to drain the rest of the fluid in the bioreactor system into the media bottle 
3. Once the bioreactor is drained, remove both polyurethane tubings from the top and 
bottom hose nipples 
4. While holding the bioreactor, unscrew one of the screws from the base mount and place 
screw and washer to the side 
5. Repeat step 1 for the other 3 screws, making sure to hold onto the bioreactor so it will not 
fall over once the screws are removed from the base mount 
6. Remove the bioreactor from the base mount and slowly pull and twist on the top steel end 
piece to remove it from the top of the glass tube 
7. Remove middle insert from the glass tube and set aside in the hood 
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8. Repeat step 6 for the bottom steel end piece to completely disassemble the bioreactor 
 
* Should be performed under a biosafety hood 
 
4. Definitions 
 
N/A 
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Title: Fluid Validation Test Protocol 
 
 
1. Purpose 
 
The purpose of this protocol is to test the fluid flow throughout the experimental bioreactor 
before conducting any sort of biological testing with cells and media. This is to ensure that there 
are no leaks within the system, and that the flow will be continuous throughout the entire system. 
This sort of validation is an important initial step, and will allow the team to troubleshoot any 
aspects of the bioreactor designs should any problems be discovered. 
 
2. Materials 
- Media bottle 
- Media bottle filled with 400 mL water to completely fill bioreactor system and 
have extra in bottle 
- 5 mm ID polyurethane tubing 
- Experimental bioreactor fully set up 
- Middle insert must be filled with glass beads 
- Peristaltic pump 
- Dye (can be any color)  
- Syringe & needle  
 
3. Procedure 
1. Set up the bioreactor, tubings, and peristaltic pump according to the described designs 
and images as shown in the design section 
2. Fill up the media bottle with a 400 mL volume of water, then place the media cap bottle 
on top. This amount should be enough to fill up the bioreactor and tubing system with 
fluid, while having enough in excess to maintain a constant source that will never run out 
3. Connect the two open ends of the tubings to two ports on the media cap bottle on the 
media bottle to create the closed-loop bioreactor system 
4. Turn on the peristaltic pump and wait for the bioreactor system to “prime” over time 
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a. “Priming” simply means when the bioreactor system and the tubings become full 
with the fluid in the media bottle 
5. Once the bioreactor system is primed, check around each area where a connection occurs 
throughout the system, this would include: 
a. Tubing connections to the media cap ports 
b. Tubing connections to the peristaltic pump 
c. Tubing connections to the top and bottom of the bioreactor 
d. Glass tube connections to each stainless steel end pieces 
6. If any problems with leakage occur, start troubleshoot process 
a. Look into modifying the system, potentially with an outer securing layer of tubing 
around the connection or utilizing additional O-rings to create water-tight seals 
wherever needed  
7. If no problems with leakage occur, proceed to the fluid dye process 
8. Connect syringe and needle by simply twisting needle into Leuer lock 
9. Draw 3 mL volume of dye into the syringe, and then place needle directly into the 
polyurethane tubing connected to the media cap port associated with the “inlet” of the 
bioreactor design 
10. Inject 1 mL of the dye into the system and follow the flow of the dye as it moves 
throughout the bioreactor system from the inlet into the outlet of the bioreactor and into 
the media bottle 
a. Be sure to note if the dye does not fully loop through the closed-loop bioreactor 
system, as this would then indicate that there is an issue with the continuous flow 
of the bioreactor  
 
4. Definitions 
 
N/A  
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Title: Control Bioreactor System Protocol 
 
 
1. Purpose  
The purpose of this protocol is to detail how a standard bioreactor system is set-up and run. The 
protocol will begin by explaining the preparation of the microcarriers in the system. This entire 
system will be used as the control in order to test the new bioreactor system against.  
 
2. Materials 
- Cytodex 1 Microcarriers 
- PBS (Ca2+, Mg2+-free) 
- Culture Medium 
- GE Bioreactor system 
 
3. Procedure 
1. Weigh out the desired amount of microcarriers to use in the bioreactor system. The 
typical concentration that will be present in the stirred-tank bioreactor is 2-3g/L. 
2. Add dry Cytodex microcarriers to a siliconized glass bottle and swell in PBS for at least 3 
hours at room temperature with occasional gentle agitation. The concentration of PBS to 
Cytodex is 50-100 mL/g. 
3. Remove the supernatant and wash the Cytodex with gentle agitation in 30-50 mL of PBS 
per gram of Cytodex for a few minutes. 
4. Discard the PBS and add fresh PBS then sterilize by autoclaving with steam from 
purified water. 
5. Prior to use, allow the microcarriers to settle, decant the supernatant and rinse the 
microcarriers in warm culture medium (20–50 mL/g Cytodex) in order to reduce dilution 
of the culture medium by PBS trapped between and within the microcarriers. Allow the 
microcarriers to settle again and remove the supernatant and resuspend the microcarriers 
in a small volume of culture medium and transfer to the culture vessel. 
6. The media and microcarriers are added to the stirred-tank bioreactor through the top port. 
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7. In order to allow the anchorage cells to attach to the microcarrier, the microcarriers and 
the medium (⅓ of total medium volume) are intermittently stirred several times and 
allowed to settle in between each stirring. 
8. In order to maintain a microcarrier culture, the stirring should then remain continuous in 
order to keep the microcarriers suspended in the culture medium.  
9. The frequency and extent of medium replenishment depends on cell type, culture density, 
culture medium and gas tension. The usual procedure is to start with replenishing 50% of 
the medium volume every 3 days, but to take advantage of conditioning effects, 
replenishment should not take place within the first 2 days of culture. If a sample is taken, 
10–20% of the medium volume can be replaced with fresh medium. 
10. The cultures should remain at confluence throughout the process so in order to ensure this 
should be continuously tested using the probes: pH, temperature, and dissolved oxygen. 
 
4. Definitions 
 
Complete Media - Growth media made previously consisting of Dulbecco’s Modified Eagle 
Media, Penicillin/Streptomycin, Fetal Bovine Serum, and Glutamax 
Intermittent Stirring - Stirring within the bioreactor at a set RPM, but with periods of stirring 
followed by periods of non-stirring  
Continuous Stirring - Stirring within the bioreactor system at a continuous set RPM without 
any interruptions 
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Title: Nutrient Testing Protocol 
 
 
1. Purpose 
 
The purpose of this protocol is to detail the testing of nutrient levels in the media of the 
bioreactor system. Daily testing of the nutrient levels will help to ensure normal cell culture 
conditions are occurring, where the adherent cells are consuming specific nutrients, while also 
releasing detectable waste byproducts as they continue to grow and proliferate. In the end, the 
team will be able to analyze this data for any specific trends to determine whether or not the cells 
are able to remain healthy, and if media replacement is necessary if cellular byproducts 
accumulate at high levels. This analysis will be looking into Glucose, Glutamax, Glutamate, 
Lactate, Ammonia, and Lactate Dehydrogenase (LDH) levels in the media.  
 
2. Materials 
- Roche Cedex Bio Analyzer 
- Sampling cuvettes from Roche 
- Experimental bioreactor system 
- Syringe 
 
3. Procedure  
1. Turn off peristaltic pump to stop the flow  
2. Place syringe into the sampling polyurethane tubing connected to one of the media bottle 
cap ports for sampling 
3. Take off hemostats and open clamp on the sample port tubing 
4. Pull syringe back in order to draw sample directly from the media bottle 
5. When ~3 mL reached in tube, close clamp and reapply hemostats 
6. Remove syringe from tubing and place ~2 mL directly into the sampling cuvette; sterility 
not major issue when transferring sample but be sure to be quick and precise after 
removing sample to limit exposure to open environment 
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7. Bring cuvette to Roche Cedex Bio Analyzer and place into an open tube in the sampling 
area 
8. On the Cedex software, input an ID for the sample and select Glucose, Glutamax, 
Glutamate, Lactate, Ammonia, and LDH sampling tests to be performed 
9. Begin processing and wait for results to appear on the screen showing nutrient levels 
10. Directly record these values into lab notebook 
11. Use the last 1 mL of the sample to perform LDH assay (refer LDH Assay Protocol) to 
obtain cell cytotoxicity data  
12. Repeat daily 
 
4. Definitions 
 
Roche Cedex Bio Analyzer - Bioprocessing monitor from Roche capable to running assays to 
detect nutrient levels 
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Title: Final Cell Density Protocol 
 
 
1. Purpose  
 
The purpose of this protocol is to assess the final cell densities of both our novel bioreactor and 
the conventional bioreactor systems for comparison. Both reactors will have been seeded at the 
same initial cell density, and therefore differences in the final cell density will highlight the 
impact of the novel bioreactor’s design on adherent cell culture. 
 
2. Materials  
 
- 100-1000 microliter pipet 
- Associated pipet tips 
- 15 mL conical tube 
- Cell culture disc 
- Trypsin  
- Incubator 
- Biosafety Hood 
- Wrench 
- Scoop 
- Scale 
- 200-micron strainer 
 
3. Procedure 
1. Refer to the Novel Bioreactor Setup and Breakdown Protocol to properly breakdown 
bioreactor to gain access to the glass beads in the middle insert 
2. Scoop a mass of beads out of the insert (0.5 gram) and place into an empty cell culture 
plate.  
3. Pipet 5ml of trypsin into the culture plate, cover, and gently agitate. Place the plate in 
incubation for 10-15 minutes. 
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4. After 10-15 minutes, remove the plate from the incubator, check to confirm that the cells 
are lifted into suspension. Apply 5ml of media to the plate, and agitate gently. 
5. Pipet the 10ml of media and beads using a serological pipet and then pass it through a 
200-micron filter into the 15ml tube. Use an additional 5ml of media to rinse the beads 
thoroughly. 
6. Place the tube in a balanced centrifuge, spin for 5 minutes and remove. Aspirate media, 
and resuspend cell pellet in 10mL of media and mix thoroughly. 
7. Prepare a slide, pipet 7 microliters onto the glass slide, and perform a cell count.  
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Appendix E: Relevant Design Calculations 
This section details all the relevant design calculations which were utilized in characterizing the 
novel packed bed bioreactor system. This includes calculations related to volumetric efficiency, 
pressure drops across the packed bed, shear forces experienced on each microcarrier, and the 
amount of oxygen delivered/consumed within the system. The first calculation, however, is 
determining the total number of cells supported within the packed bed, as this is a baseline 
calculation that the rest of the calculations utilize. 
 
Total Number of Beads Calculation 
In order to perform any calculation, the total number of beads within the bioreactor system must 
be known. This is performed by dividing the volume of the bioreactor vessel by the volume of 
beads, under the assumption that the densest possible packing efficiency if 74%, meaning that 
74% of the bioreactor vessel volume contains beads [33]: 
 
Beadstotal =
η ∗ Volumetube
Volumebeads
=
0.74 ∗ Volumetube
Volumebeads
 
 
The volume of the bioreactor glass tube can be defined as its length multiplied by its area. The 
volume of a bead is simply the volume of a sphere, which is defined as 4/3*π*radius of the 
microcarrier. As a result: 
 
Beadstotal =
0.74 ∗ Volumetube
Volumebeads
=
0.74 ∗ Ltube ∗ Atube
Volumebeads
=
0.74 ∗ πrtube ∗ Ltube
4
3 ∗ π ∗ rbead
 
 
The radius of the bioreactor vessel is simply the inner diameter of the glass tube divided by two. 
The inner diameter of the glass tube is known as 30.1 mm. The diameter of the glass bead is 
known as 512.5 µm or 512.5*10-6 m, as the provided glass beads are Megalux Uncoated Glass 
Beads with a known diameter range of 425 - 600 µm. 512.5 µm is used for the diameter under 
the assumption of monodispersity. The length of the packed bed to be used for this calculation 
and all subsequent calculations is 0.1 m, as this is nearly the entire length of the middle insert 
while leaving just a little bit of wiggle room inside the insert. As such, the total number of beads 
can be calculated as: 
 
Beadstotal =
0.74 ∗ πrtube
2 ∗ Ltube
4
3 ∗ π ∗ rbead
3
=
0.74 ∗ π ∗ (
30.1 mm
2 ∗ 1000 mm/m
)2 ∗ 0.1m
4
3
∗ π ∗ (
512.5 ∗ 10−6m
2
)3
= 7.47 x 105 beads 
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 As such, with a packed bed the length of 0.1m inside the middle insert, the total number 
of beads is 7.47 x 105.  
 
Volumetric Efficiency Calculations 
This section will focus on how the volumetric efficiency is calculated for both the Cytodex and 
Bioreactor systems and then compared. First, the total number of cells per surface area is 
calculated with the 100% confluency experiment. The total number of cells was found to be 1.14 
x 106 cells. Knowing that a T-flask has a surface area of 25 cm2: 
 
Total # cells
Surface area
=
1.14 x 106 cells
25 cm2
∗
1 cm2
1 x 108 μm2
= 4.55 x 10−4 cells/μm2 
 
 Next, the total surface area per unit volume of the bioreactor system must be calculated. 
Utilizing the GE manual, it is known that for every gram of dry weight of the Cytodex 
microcarriers, there is a total surface area of 4400 cm2 [32]. When interviewing with Chris 
Bellerive from the BETC, it was determined that typically 3-7 g of Cytodex is used per L of the 
bioreactor system. As such, the surface area per unit volume can be calculated: 
 
SA
V Cytodex
=
3 g Cytodex
1 L volume
∗
4400 cm2
1 g Cytodex
∗
1 ∗ 108 μm2
1 cm2
= 1.32 x 1012 μm2/L 
 
 The surface area per unit volume of the novel bioreactor system can be calculated 
knowing the total number of beads in the system. This is done by multiplying the surface area of 
one bead by the total number of beads in the system to determine the total surface area, as 
shown: 
 
SAbead = 4πr
2 = 4π ∗ (
512.5 μm
2
)2 = 8.25 x 105 μm2/bead 
SApacked bed = SAbead ∗ Beadstotal = 8.25 x 10
5 μm2/bead ∗ 7.47 x 105 beads 
SApacked bed = 6.16 x 10
11 μm2 
 
 Next, the volume of the packed bed system can be calculated, knowing that the length is 
0.1 m and the diameter is 30.1 mm: 
 
Vbed = Lbed ∗ Atube = Lbed ∗ πrtube
2 = 0.1 m ∗ π(
30.1 mm
2 ∗ 1000 
mm
m
)2
= 7.12 x 10−5 m3 
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 Now, the surface area to volume ratio of the packed bed can be calculated: 
 
SA
V bed
=
SApacked bed
Vbed
=
6.16 x 1011 μm2
7.12 x 10−5 m3
∗
1 m3
1000 mL
= 8.66 x 1012 μm2/L  
 
 Now that the surface area to volume ratios are calculated for both systems, the total 
number of cells supported per volume can be determined by multiplying each ratio by the 
previous total number of cells per unit surface area calculation. The calculated cells supported 
per volume is the volumetric efficiency of the system. As such, volumetric efficiency can be 
calculated for the Cytodex system as shown, where VE is the volumetric efficiency: 
 
VE =
SA
V
∗
Total # cells
Surface area
 
 
VECytodex =
SA
V Cytodex
∗
Total # cells
Surface area
= 1.32 x 1012  
μm2
L
∗ 4.55 x 10−4  
cells
μm2
∗
1 L
1000 mL
= 
6.01 x 105  
cells
mL
 
 
 The same equations are applied for the packed bed system: 
 
VEbed =
SA
V bed
∗
Total # cells
Surface area
= 8.66 x 1012  
μm2
L
∗ 4.55 x 10−4  
cells
μm2
∗
1 L
1000 mL
=  
39.3 x 105  
cells
mL
 
 
 Now that the total number of cells per volume is calculated for both systems, the 
volumetric efficiencies can simply be divided to determine the increase in volumetric efficiency 
between the packed bed system and the Cytodex system: 
 
39.3 x 105  
cells
mL
6.01 x 105  
cells
mL
= 6.56 
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 As such, it is determined that the packed bed reactor is 6.56-times more volumetrically 
efficient than the Cytodex system since it can support 6.56-times more cells per unit volume.  
 
Ergun Equation Calculations 
This section will focus on how the Ergun Equation as described in Equation (2) is utilized to 
derive the pressure drop across the packed bed of microcarriers as a function of the flow rate 
provided by the peristaltic pump. Several assumptions were utilized for this equation: 
- The void space between each particle is 0.26, under the assumption of the densest 
possible packing of spheres being 74% 
- Fluid properties such as viscosity and density of the cell culture media are assumed to be 
that of water at 37℃, since the bioreactor will be running in the incubator 
- Monodispersity is assumed for the spheres, as the sample given from the manufacturers 
contains a range of diameters from 415-600 µm; as such, the median diameter of 512.5 
µm is assumed 
 
First, we start off with the Ergun Equation, as described by Equation (2): 
 
ΔP = (
150μ(1−ε)2u0
ε3dp
2 +
1.75(1−ε)ρu0
2
ε3dp
) ∗ L             (2) 
 
where ΔP is the calculated pressure drop, L is the height/length of the packed bed, µ is the fluid 
viscosity, ε is the void space within the packed bed, u0 is the fluid superficial velocity, dp is the 
diameter of the particles in the packed bed, and ⍴ is the density of the fluid. 
 
With the given assumptions, we know: 
 
ε = 0.26 
⍴ = 997 kg/m3 
µ = 6.922*10-4 kg/(m*s) 
dp = 512.5 µm = 512.5 * 10
-6 m 
L = 0.1 m 
 
The fluid superficial velocity is a variable that can be calculated because with a provided 
volumetric flow rate, while the area of the bioreactor vessel is known as 30.1 mm: 
 
u0 =
Q
A
=
Q [m3/s]
π(
30.1 mm
2
∗
1 m
1000 mm
)2
=
Q [m3/s]
7.12 x 10−4 m2
 [m/s] 
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Now, all of these constants can be plugged into the Equation (2) to derive the pressure drop as a 
function of velocity: 
 
ΔP = (
150 ∗ (6.922 ∗ 10−4  
kg
m ∗ s
) ∗ (1 − 0.26)2 ∗ (u0
m
s
)
(0.26)3 ∗ (512.5 x 10−6m)2
+
1.75 ∗ (1 − 0.26) ∗ (997 
kg
m3
) ∗ (u0
m
s
)2
(0.26)3 ∗ (512.5 x 10−6m)
) ∗ (0.1 m) 
ΔP = 1.23 x 106 ∗ (u0)
kg
m ∗ s2
+ 1.43 x 107 ∗ (u0)
2
kg
m ∗ s2
 
 
A sample calculation is shown below with a flow rate of 50 mL/min: 
First, the fluid velocity is calculated utilizing the volumetric flow rate: 
 
Q = 50 
mL
min
∗
1 x 10−6 m3
1 mL
∗
1 min
60 s
= 8.33 x 10−7 m3/s 
u0 =
8.33 x 10−7 [m3/s]
7.12 x 10−4 m2
= 1.17 x 10−3 m/s 
 
Once the fluid velocity is calculated, it can be plugged into the simplified Ergun Equation 
 
ΔP = 1.23 x 106 ∗ (1.17 x 10−3)
kg
m ∗ s2
+ 1.43 x 107 ∗ (1.17 x 10−3)2
kg
m ∗ s2
 
ΔP = 1.46 x 103 Pa 
 
Shear Stress Calculations 
Now that pressure drops can be calculated from the Ergun Equation, these pressure differentials 
can be utilized to calculate the shear stress experienced on the surface of each microcarrier with 
Equation (3). This equation will be utilized to derive the shear stress as a function of the 
volumetric flow: 
 
τ =
ΔP∗A
SA
                  (3) 
 
where τ is the calculated shear stress, ΔP is the calculated pressure drop from Equation (2), A is 
the cross sectional area of the fluid flow, and SA is the surface area of the packed bed. 
 
The cross sectional area of the fluid flow can be described as, 
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A =
πD2ε
4
 
 
where A is the cross sectional area of the fluid flow, D is the diameter of the bioreactor vessel 
and ε is the packed bed void space. The diameter of the bioreactor vessel is known as 30.1 mm, 
while the voice space of the packed bed is known as 0.26, as described above since the densest 
possible packing is assumed as 74% for spheres.  
 
Determining the surface area of the scaffold will involve knowing the surface area of beads 
within a specific volume. The surface area of the scaffold can be defined as the surface area of 
the total number of beads in a volume of the packed bed. This is simply the surface area of one 
bead multiplied by the number of beads previously calculated above, which will yield the total 
surface area. As such, the surface area of the scaffold as a function of the length of the packed 
bed can be derived as: 
 
SA = SAbeads ∗ 7.47 x 10
5 beads 
SA = 4πrbead
2 ∗ 7.47 x 105 beads 
SA = 4π(
512.5 x 10−6m
2
)2 ∗ 7.47 x 105 beads 
SA = 6.16 x 10−1 m2 
 
Now that the scaffold surface area is a function of length, the shear stress calculated from the 
Ergun Equation is a function of length, such that: 
 
τ = ΔP ∗
πD2ε
4
∗
1
6.16 x 10−1 m2
 
 
A sample calculation is shown below, utilizing the pressure drop calculated from the Ergun 
Equation for a volumetric flow rate of 50 mL/min: 
 
τ = 1.46 x 103 Pa ∗
π(30.1 mm / 1000 mm/m)2 ∗ (0.26)
4
∗
1
6.16 x 10−1 m2
 
τ = 4.41 x 10−1 Pa = 4.41 dynes/cm2 
 
When these calculations are performed for the volumetric flow range of 30-75 mL/min, it is 
found that the shear stress limit of 6.5-10 dynes/cm2 is reached at around a flow range of 75 
mL/min, indicating that the provided peristaltic pump with a flow rate of 56.8 mL/min will not 
exceed this shear stress limit.  
127 
 
Oxygenation Calculations 
Oxygenation validation involves the calculation of the total amount of oxygen that is delivered 
into the bioreactor system in comparison to the total amount of oxygen that is consumed within 
the system. First, this will involve calculating the total amount of oxygen consumed by the 
system. This is done utilizing Equation (4), which is  
 
O2,C = Ccells ∗ O2,cell               (4) 
 
where O2,C is the maximum amount of oxygen consumed, Ccells is the maximum amount of cells 
in the packed bed, and O2,cell is the theoretical oxygen consumption rate per cell. 
 
This calculation is performed under the assumption that the packed bed is at maximum 
confluence, with each cell consuming oxygen at its maximum possible rate. The total amount of 
beads within the packed bed system has already been calculated above as 7.47 x 105 beads. This 
can be converted into the total number of cells under the assumption of maximum confluency on 
every bead. Utilizing the previous confluency calculations, it was found that when a bead is 
100% confluent, it will contain 375 cells per bead. As such: 
 
Ccells = 375 
cells
bead
 ∗  7.47 x 105 beads 
𝐶𝑐𝑒𝑙𝑙𝑠 = 2.80 𝑥 10
8 𝑐𝑒𝑙𝑙𝑠 
 
Next, the maximum theoretical amount of oxygen consumed by a fibroblast cell must be 
determined. Examining literature, it was found that 1.19 x 10-17 mol of oxygen is consumed by a 
fibroblast cell every second [35]. As such the total amount of oxygen consumption within a 
packed bed as a function of the length of the packed bed is calculated as: 
 
O2,C = 2.80 x 10
8 cells ∗ 1.19 x 10−17  
mol O2
cell ∗ s
= 3.33 x 10−9
mol O2
s
 
 
O2,C = 3.33 x 10
−8
mol O2
s
∗  
32 g O2
mol O2
 ∗
1000 mg
1 g
= 1.07 x 10−4mg O2/sec 
 
This states that the total amount of oxygen consumed by a packed bed with the length of 0.1 m is 
1.07 x 10-4 mg every second. This will be the baseline comparison that the total amount of 
oxygen delivered will be compared against.  
 
Next, the total amount of oxygen delivered by the system must be determined as a function of 
flow rate. This is done utilizing Equation (5), which is: 
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O2,D = DO2 ∗ Q                            (5) 
 
where O2,D is the calculated rate of oxygen delivery, DO2 is the theoretical dissolved oxygen in 
media, and Q is the volumetric flow rate of the pump into the bioreactor vessel. 
 
First, the theoretical amount of dissolved oxygen in the media must be determined. This is 
performed under the assumption that this amount of dissolved oxygen is equivalent to the 
amount of dissolved oxygen in water. Additionally, this should be calculated at 37℃ since this 
will be operating within incubator conditions. As such, it was found that the maximum dissolved 
oxygen concentration in water at 37℃ is 6.71 mg/L [34]. A safety factor is factored into this 
concentration since it is highly unlikely that this maximum concentration will be achieved within 
the incubator, and as such the dissolved oxygen concentration is taken as 4.00 mg/L. This can be 
converted into: 
 
DO2 = 4.00 
mg
L
∗
1 L
1 ∗ 106mm3
= 4 x 10−6 mg/mm3 
 
Now, the total amount of oxygen delivered into the system can be derived as: 
 
O2,D = Q ∗ 4 x 10
−6 mg/mm3 [mg/s] 
 
An example calculation is shown with a volumetric flow rate of 50 mL/min. The volumetric flow 
rate of the pump is given as a constant 50 mL/min, which can be converted into: 
 
Q = 50 
mL
min
∗
1 min
60 s
∗
1000 mm3
1 mL
= 8.33  x 102 mm3/s 
 
Now, this can be plugged into the total amount of oxygen delivered function:  
 
O2,D = 8.33 x 10
2 mm3/s ∗ 4 x 10−6 mg/mm3 [mg/s] 
O2,D = 33.3 x 10
−4 mg/s 
 
This states that for a flow rate of 50 mL/min, the total amount of oxygen delivered to the packed 
bed is 33.3 x 10-4 mg every second. In comparison, 1.07 x 10-4 mg of oxygen is consumed every 
second, thereby verifying that the bioreactor vessel would be able to support the oxygen 
requirements of the packed bed of microcarriers with a length of 0.1 m.  
 
 
